Curriculum Vita of Craig G. Burkhart, MD, MPH

Home 4556 Crossfields Road, Toledo, Ohio 43560

Office 5600 Monroe Street, Suite 106B
Sylvania, Ohio 43560
419-885-3403
fax 419-885-3401


Wife
Anna Kristiina Jutila Burkhart, CPA, JD, CFP, MBA


Children
Kristiina Maria Burkhart Farrell, MBA

Craig Nathaniel Burkhart, MSBS, MD

Heidi Rebecca Burkhart, BA


Grandchildren
Blaine Michael Farrell

Brennen Thomas Farrell

Kian Patrick Farrell

Brea Kristine Farrell

Camden Nathaniel Burkhart

Paxton Watts Burkhart

Email This email address is being protected from spambots. You need JavaScript enabled to view it.
 

Education
B.A. (summa cum laude), University of Pennsylvania, 1972

M. D., Medical College of Ohio at Toledo, 1975

M.P.H., University of Toledo, 1983

Internship
University of Michigan Hospital, Ann Arbor, Internal Medicine, 7/75-6/76
 

Dermatology Residency

University of Michigan Hospital, Ann Arbor, 7/76-6/79 


Present Academic Appointments

Clinical Professor, Department of Medicine, Medical College of Ohio, 7/98-present

Clinical Assistant Professor, Department of Medicine, Ohio University College of Osteopathic Medicine, 1982-present


Past Academic Appointments

Assistant Professor, Department of Medicine, Medical College of Ohio, 7/1979-6/1982
Head of Dermatology, Medical College of Ohio, 7/79-6/82
Head of Phototherapy Unit, Medical College of Ohio, 7/79-6/82
Clinical Assistant Professor, Department of Medicine, Medical College of Ohio, 7/82-6/98


Specialty Certification
Dermatology, American Board of Dermatology, 1979
Recertified, American Board of Dermatology, 1999
Recertified, American Board of Dermatology, 2007


Research Grants
F. M. Douglass Foundation and St. Vincent Mercy Medical Center, Grant #98-181, for head lice research on nit sheath, 1998-1999.

Warner-Lambert Pharmaceutical Grant for nationwide survey of school nurses regarding opinions on head lice, 1998-1999.

F. M. Douglass Foundation and St. Vincent Mercy Medical Center, Grant #00-203, for further analysis of proteinaceous composition of louse sheath, 2000-2001.

F. M. Douglass Foundation and St. Vincent Mercy Medical Center, Grant #01-212, for assessment of bacterial symbiotes in head lice, 2001-2002. 

Bryan & Klein, LLC, unrestricted educational grant for head lice, 2003-4

Taro Pharmaceuticals USA, Inc., unrestricted educational grant for head lice, 2003-4

Research Company 
Co-founder and President of Gar-Nat Laboratory, Inc.
 

Patents 
U.S. Patent #6103248, Topical preparation and therapy for head lice, awarded August 15, 2000
U.S. Patent #6417179, Ear wax solution, awarded July 9 2002. 
U.S. Patent #6524602, Polymer delivery system for parasitic diseases, awarded February 27, 2003
U.S. Patent #6737070, Benzoyl Peroxide and tertiary amines, awarded May 18, 2004
U.S. Patent #7323185, Methods of increasing the efficacy of peroxides, awarded January 29, 2008
U.S. Patent #7326420, Benzoyl peroxide compositions having increased potency, March 14, 2008


Sold Patents 
U.S. Patent #6103248 
U.S. Patent #6417179
U.S. Patent #6524602

 
Very Special Honors
Owner of six patents (with some also pending)
Past Head of Dermatology at University of Toledo College of Medicine
Inaugural class of inductees into Ottawa Hills High School Distinguished Alumni Award 2017
Distinguished Service Award from the Ohio Dermatological Association, 2018 


Editor in Chief:

Journal of Dermatology and Allergy for the Practicing Physician
The Open Dermatology Journal
Ohio Dermatological Association Newsletter (co-editor)
Dermatology Research and Practice (co-editor)
World Research Journal of Medicine (associate editor)
Annals of Clinical and Medical Microbiology (associate editor)
Dermatology Clinics and Research (co-editor)
 

Editorial Board of:

Journal of Current Adolescent Medicine, Ohio State Medical Journal, Dermatology News, Cortlandt Forum, The Open Dermatology Journal, Open Dermatology Letters, Open Dermatology Reviews, Dermatology Research and Practice,  Open Access Journal of Science and Technology, Global Journal of Dermatology and Venereology, Journal of Cardiology and Therapy, Austin Journal of Allergy and Therapy, and Journal of Experimental Dermatology and Clinical Research, Journal of Procedural Dermatology, Journal of Clinical and Investigational Dermatology, Annals of Clinical and Medical Microbiology, Heliyon, Journal of Dermatological Research, Journal of Clinical and Cosmetic Dermatology, Journal of Dermatology and Plastic Surgery, Dermatology Clinics and Research, and Journal of Biology and Nature

Board of Directors for Topaz Pharmaceuticals

Treatment Advisory Board, Ohio State Medical Board

Inaugural class of inductees into Ottawa Hills High School Distinguished Alumni Award

Quoted in various other magazines and newspapers including U.S. News and Business Report, Allure, Maxim, and Wall Street Journal 

Editorial consultant to the American College of Physicians for Physicians’ Information and Education Resource

Editorial Board of several journals including  Journal of Current Adolescent Medicine, Ohio State Medical Journal, Dermatology News, Cortlandt Forum, The Open Dermatology Journal, The Open Pathology Journal, Open Dermatology Letters, Open Dermatology Reviews, Dermatology Research and Practice, North 

American Journal of Medical Sciences.

Honorary Editorial Board of 'Medical Equipment Insights', published by Libertas Academica

Listed in Marquis’s Who’s Who in America, from 42nd edition (1984-5) thru present   

Listed in Marquis’s Who’s Who in the World, from 1984-5 (2nd edition) thru present 

Co-founder and President of Gar-Nat Laboratory, Inc.

Owner of patents in the field of acne, anti-fungal agents, head lice, and ear wax

Past President of the Ohio Dermatologic Society

Past President of the Toledo Area Phi Beta Kappa Graduate Association

President of the University of Toledo Medical Alumnae Association

Vice-President and Secretary of Classicala Farms, Inc. 

Vice-President, Western Lake Erie Dermatological Society

Included in ‘The Best Doctors in America’ by Woodward/White, Inc. for 10 consecutive years thru 2018

Listed in Consumers’ Research Council of America’s “Guide to America’s Top Physicians” 

Listed in International Association of Dermatologists “The Leading Physicians of the World”

Listed in SLD Industries America’s Top Dermatologists

College of Health and Human Service Distinguished Alumni Award Recipient from the University of Toledo Public Health Department

Honor roll for the Phi Beta Kappa Society

Part of management team of Topaz Pharmaceuticals

Participant in American Academy of Dermatology Self-Assessment Workshops

Participant and formulator of American Academy of Dermatology’s Self Assessment Question of the Week 


Journal Editorship 


Editor in Chief: 

Journal of Dermatology and Allergy for the Practicing Physician

The Open Dermatology Journal


Co-editor

Ohio Dermatologic State

Dermatology Research and Practice

Associate Editor

World Research Journal of Medicine

Guest editor for special issue on “Biofilms in Dermatology” Dermatology Research and Practice

Editorial consultant: 

American College of Physicians for Physicians’ Information and Education Resource

Books:

Management and Control of Head Lice Infestations, Jorg Heukelbach, CG Burkhart, CN Burkhart, et al.  2010, Uni-Med Science. 


Book Chapters 
Burkhart CN, Burkhart CG.  Scabies, Other Mites, and Pediculosis.  In: Goldsmith LA, Katz SI, Bilchrest BA, Paller AS, Leffell DJ, Wolff K (eds); Fitzpatrick’s Dermatology in General Medicine.  New York, 2012.  

Meinking TL, Burkhart CN, Burkhart CG.  Scabies. In: American College of Physicians/American Society of Internal Medicine, PIER module, Online Textbook of Internal Medicine (http://pier.acponline.org), 2001. 

Meinking TL, Burkhart CN, Burkhart CG.  Changing Paradigms in Dermatology:  Common Dermatological Helminthic Infections and Cutaneous Myiasis.  In: Parrish L, Abromovits W (eds); Clinics in Dermatology. New York: Mosby, 21(5):407-416.

Meinking TL, Burkhart CN, Burkhart CG.  Infestations.  In: Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mascaro JM, Salasche SJ, Saurat J, Siegfried E, Stingle G (eds); Dermatology.  London: Harcourt Health Sciences Publishers Ltd, 2003.

Burkhart CN, Burkhart CG.  Infestations.  In: Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mascaro JM, Salasche SJ, Saurat J, Siegfried E, Stingle G (eds); Dermatology.  2ND edition.  London: Harcourt Health Sciences Publishers Ltd, 2008.

Burkhart CN, Burkhart CG.  Infestations.  In: Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mascaro JM, Salasche SJ, Saurat J, Siegfried E, Stingle G (eds); Dermatology.  3rd edition.  London: Harcourt Health Sciences Publishers Ltd, 2014.

Burkhart CG.  “Meditation in Art” in The Sound of Poetry, a 33 –tract, three album CD set, April, 2005.

Meinking TL, Burkhart CG, Burkhart CN.  Ectoparasitic Diseases in Dermatology: Reassessment of Scabies and Pediculosis.  In: James WD (ed.); Advances in Dermatology, Volume 15.  St. Louis, Missouri: Mosby, 1999;67-108.

Burkhart CN, Burkhart CG, Morrell DS.  Infestations.  In: Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mascaro JM, Salasche SJ, Saurat J, Siegfried E, Stingle G (eds); Dermatology.  3rd edition.  London: Harcourt Health Sciences Publishers Ltd, 2017.

(Note:  author of all 5 of the first editions of textbook) 

Burkhart CG, Burkhart CN.  Ochronosis.  In:  James WD, Elston D (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.com). St. Petersburg: eMedicine Corporation, 2000.

Burkhart CG, Burkhart CN.  Folliculoma.  In: James WD, Elston D (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.com). St. Petersburg: eMedicine Corporation, 2000.

Burkhart CG, Gottwald L.  Tinea Versicolor. In: James WD, Elston D (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.com). St. Petersburg: eMedicine Corporation, 2000.

Burkhart CG.  What’s New in Insect Allergy.  In:  Stone SP (ed.); Dialogues in Dermatology.  Schaumburg, Illinois, American Academy of Dermatology, 1983.

Meinking TL, Burkhart CN, Burkhart CG.  Scabies. In: American College of Physicians/American Society of Internal Medicine, PIER module, Online Textbook of Internal Medicine (http://pier.acponline.org), 2005 (revision).

Burkhart CG, Burkhart CN.  Ochronosis.  In:  James WD, Elston D (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.com). St. Petersburg: eMedicine Corporation, 2005 (revision).

Burkhart CG, Burkhart CN.  Folliculoma.  In: James WD, Elston D (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.com). St. Petersburg: eMedicine Corporation, 2005 (revision).

Burkhart CG, Gottwald L.  Tinea Versicolor. In: James WD, Elston D (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.com). St. Petersburg: eMedicine Corporation, 2005 (revision).

Tcheung J, Burkhart CG, Burkhart CN.  Potential future treatments focusing on eradication of symbiotic bacteria.  In: Head lice infestations—current aspects, therapy, and control, 2010.

Burkhart CG, Ngyen, N.  Talon noir (black heel). In:  Clinical Decision Support: Dermatology, 2011.

Burkhart CG, Ngyen.  Piezogenic pedal papules. In:  Clinical Decision Support: Dermatology, 2011. 

Burkhart CN, Burkhart CG, Morrell DS.  Treatment of tinea versicolor.  Evidence Based Dermatology, published by PMPH, 2011. 

Crites MS, Burkhart CG, Burkhart CN.  The role of microbiology and biofilms in acne.  World Clinics in Dermatology 2013;1(1):1-8. 

Nguyen N, Burkhart CG.  Super nummary nipple.  In: James WE, Elston D (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.com).  St. Petersburg: eMedicine Corporation (2014). 

Burkhart CN, Burkhart CG, Morrell DS.  Infestations.  In: Bolognia JL, Schaffer JV, Cerroni L (eds); Dermatology.  4rd edition.  London: Harcourt Health Sciences Publishers Ltd, 2019. 

Wheat CM, Burkhart CN, Burkhart CG, Cohen BA  Scabies, Other Mites, and Pediculosis.  In: Goldsmith LA, Katz SI, Bilchrest BA, Paller AS, Leffell DJ, Wolff K (eds); Fitzpatrick’s Dermatology in General Medicine.  New York, 2019.     

Note:  Many of these book chapters have also been updated for later editions as well

Member of Editorial Board: 
Journal of Current Adolescent Medicine

Clinical Pediatric Dermatology

Ohio State Medical Journal

Dermatology News

Cortlandt Forum

The Open Dermatology Journal

Open Dermatology Letters

Open Dermatology Reviews

American Hospital Formulary Service for Patient Drug Information

Open Pathology Journal

Dermatology Research and Practice

British Medical Journal Point of Care

Global Journal of Dermatology and Venereology

Journal of Clinical and Investigational Dermatology

North American Journal of Medical Sciences, 

Open Access Journal of Science and Technology

Austin Journal of Allergy

Journal of Experimental Dermatology and Clinical Research

Annals of Clinical and Medical Microbiology

Journal of Cardiology and Therapy

Dermatology – Open Journal

Journal of Clinical Microbiology and Biochemical Technology

 

Consultant (including reviewing articles)  

New England Journal of Medicine, SCIENCE, International Journal of Molecular Science, International Journal of Cardiology, Archives of Dermatology, Journal of the American Academy of Dermatology, Annals of Internal Medicine, Ohio State Medical Journal, Journal of Adolescent Medicine, Pediatric Drugs, Pediatric Dermatology, Hospital Physician, Journal of Medical Entomology, Oral Surgery, British Journal of Dermatology, Journal of the Tropical Medicine and Health, Journal of Molecular Catalysis, Archives of Immunology and Experimental Therapy, Expert Opinion in Pharmacology, Journal of Skin Pharmacology and Physiology, Journal of Parasitology, Journal of Cutaneous Medicine and Surgery, Lancet, Lancet Infectious Disease, Expert Review of Anti-infective Therapy, Archives of Diseases in Childhood, Clinical and Experimental Dermatology, International Journal of Sexually Transmitted Diseases and AIDS, Clinical Infectious Diseases, Journal of the European Academy of Dermatology and Venerology, Parasitology International, Recent Reviews on Clinical Trials, Expert Review of Dermatology, Journal of Drugs in Dermatology, Archives of Dermatological Research, Skin Pharmacology and Physiology, European Journal of Lipid Science and Technology, Journal of Virological Methods, Expert Review of Dermatology,  Saudi Medical Journal, Plos One, Journal of Medicinal Plant and Herbal Therapy Research, Clinical and Experimental Dermatology, Clinical and Experimental Ophthalmology, Current Microbiology, Italian Journal of Pediatrics, Journal of the European Academy of Dermatology and Venereology,  Journal of Insect Physiology, British Journal of Dermatology, Expert Review of Anti-Infective Therapy, African Journal of Agricultural Research, Journal of Pharmacy Practice and Research, Disease Markers, Lancet Infectious Disease, Nutrition and Metabolism, Industrial and Engineering Chemical Research, Clinical and Experimental Dermatology, Clinical Pediatric Dermatology: Open Access, Case Reports in Medicine, Review in Recent Clinical Trials, Nutrition Research, Journal of Infection, Journal of Occupational and Environmental Medicine, Journal of Clinical and Experimental Dermatology, Occupational Health Southern Africa, Journal of Medical Hypotheses, International Journal of Environmental Research and Public Health, Biofouling, and Expert Review of Dermatology. 
 

Professional Societies and Activities

Ohio Dermatology Medical Association (Past President, Advisory Trustee, and member of Board of Trustees)

Ohio Dermatology Foundation (Board of Trustees)

Toledo Area Phi Beta Kappa Graduate Association (past president and presently treasurer)

Western Lake Erie Dermatological Society (Vice-President)

University of Toledo College of Medicine and Alumni Affiliate (Board of Directors and Past President)

University of Toledo Alumni Association (Board of Directors)

American Academy of Dermatology (active member)

Toledo Academy of Medicine (board of directors)

Ohio State Medical Association (Editorial Board of its publication)

Association of Military Dermatologists (lifetime member)

Michigan Dermatology Association (Committee chairman)

United Chapters of Phi Beta Kappa Graduate Association

American Society of Cosmetic Dermatology and Aesthetic Surgery

Alumni Association, University of Michigan

International Arabian Horse Association

American Horse Association of Michigan

Sarcoptes-World Molecular Network

International Association of Dermatologists
 

Service on Committees 

Head of Dermatology Indigent Clinic at Toledo Hospital, 1982-1997

Initiated and Head of Free Head Lice Clinic for Northwest Ohio Schools and School Nurses, 1997-2002

Industrial Hygiene Masters Program Advisory Committee, 1980-82

Institutional Task Force Committee for LCME Self-Study, 1980

Regional Director of National Melanoma Screening Service, 1987-2000

Head of Medical School ten-year Reunion Committee for 1975 graduating class at medical school

Chairman of First Ten-Year Reunion at Medical College of Ohio, 1982

Director of Michigan Dermatological Meeting at Medical College of Ohio, 10/14/81

Membership Service Commission of Academy of Medicine for Toledo and Lucas County, 1982-3

Scientific Investigation and Research Committee of the Michigan Dermatological Association, 1981-1986

Pharmacy Committee, Ohio Dermatology Medical Association, 1988

Advisory Board, ProMedica Health System, 1997-1998

Medical Advisor of Lupus Society of Arthritis Foundation for Northwest Ohio, 1992-1998

Director of indigent medical clinic for dermatology at Toledo Hospital, 1982-1994

Library Committee, St. Charles Hospital, 1993-2003

Library Committee, Toledo Hospital, 1998-present

Head of Section of Dermatology, Department of Medicine, St. Charles Mercy Hospital, 1983-2003

Head of Section of Dermatology, Department of Medicine, Riverside Mercy Hospital, 1987-1998

Head of Section of Dermatology, Department of Medicine, Flower Hospital, 1982-1984

Head of Section of Dermatology, Department of Medicine, Toledo Hospital, 1992-1998

Head of Section of Dermatology, Department of Medicine, St. Vincent Mercy Hospital, 2002-

St. Charles physician leadership retreat, 5/00

Honorary Chairman of the National Republican Congressional Committee’s Physician’s Advisory Board for State of Ohio, Congressman Tom DeLay, House Majority Whip, Chairman, 2000

Director of 25th Medial School Reunion 2000, Medical College of Ohio, Hilton Head, South Carolina, 7/19-7/21/00

Vice-President and Secretary of Classicala Farms, Inc.  1999-

Vice-President, Western Lake Erie Dermatological Society, 2002-

Elected to the Board of Directors of the Ohio Dermatological Society, 2002-2007

Councilor for the Toledo and Northwest Ohio Academy of Medicine, 2003-2005

Chairman of the Nominating Committee of the Toledo and Northwest Ohio Academy of Medicine, 2004-5.

PIER Editorial Consultant for the American College of Physicians for section on parasitic diseases, 2004-

Established and Chairman of the Membership Service Committee of the Ohio Dermatological Association, 2004-2007.

Adviser for the EuroMDnet (www.euromednet.org) to create a database of experts participating in an international continuing medical education via a secure website

President, Ohio Dermatological Society, 2005-

Board of Directors of University of Toledo Alumni Association, 2006-9

Peer Review Consultant for Map of Medicine for Medic to Medic, a clinical algorithm/pathway, for section on helminthes, 2006-

Assistant Editor of the Ohio Dermatology Association Newsletter, 2006-

Ohio Dermatologic Foundation Trustee, 2006-

Ohio Dermatologic Foundation Nominating Committee, 2006-2008

Co-Chair of the Third International Congress of Phthiraptera in Buenos Aires, Argentina, October 16-20, 2006

Member of the Contact Allergic Dermatitis Panel Committee, Ohio Dermatology Association, 2007-

Established and Chairman of the Public Health and Public Relations Committee for the Ohio Dermatological Association, 2006-

Established and Chairman of the Charitable Donations Committee for the Ohio Dermatological Association, 2006-2008

Chairman of ad hoc committee on the Disclosure statement to Potential Conflict of Interest of board members and officers for the Ohio Dermatological Association, 2007-

Membership Committee of the Ohio Dermatological Association, 2006-

Chairman of the Nominating Committee, Ohio Dermatological Association, 2007-9.

Chairman of Bylaws Committee, Ohio Dermatological Association, 2007-

Chairman of Charitable Donations Committee, Ohio Dermatological Association, 2006-

Assistant Editor, Ohio Dermatological Association Newsletter, 2006-

Chairman of Public Health Committee, Ohio Dermatological Association, 2007-

Co-Chairman of Public Relations Committee, Ohio Dermatological Association, 2007-

Co-Chairman of Scientific Committee, Ohio Dermatological Association, 2007-

New Global Thought Leader in management of onychomycosis, 2008-present

Chairman of the Bylaws Committee, Ohio Dermatological Society, 2008-present

Chairman of ad hoc committee to assess physician assistants as members of Ohio Dermatological Association, 2008

Ohio Dermatology Association Advisory Trustee 2007-2011

American Academy of Dermatology's Clinical Guidelines Committee, 2013

Recognition as Reviewer, Journal of Infection, 2015

President of the University of Toledo Medical Alumni Association, 2014-2015

Toledo Area Chamber of Commerce, 2010-
 

Awards and Commendations 

Phi Beta Kappa, University of Pennsylvania, 1972

Joseph Collins M.D. Scholarship Award Recipient, 1973-1975

Inaugural class of inductees into Ottawa Hills High School Distinguished Alumni Award

Listed in Marquis’s Who’s Who in America, from 42nd edition (1984-5) thru present 

Listed in Marquis’s Who’s Who in the World, from 1984-5 (2nd edition) thru present 

Editor-in-Chief, Journal of Dermatology and Allergy for the Practicing Physician, 1980-1983

Editorial Board member, Journal of Current Adolescent Medicine, 1980-1982

Editorial Advisory Board Member, Ohio State Medical Journal, 1982-1989

Trustee of Board of Directors, Toledo Area Phi Beta Kappa Graduate Association, 1982-present

President of Toledo Area Phi Beta Kappa, 1984-1986

Treasurer of Toledo Area Phi Beta Kappa, 1986-present

Speakers’ Bureau for several pharmaceutical Companies including Norvartis, Johnson and Johnson, Smith Kline Beecham, Burroughs Welcome, Taro 

Ranked nationally and regionally in junior and adult tennis, won the Ohio state high school tennis tournament in 1969, ranked in top ten of Open Men’s Division in Northwest Ohio as late as 1997

Landscaper for Garden Tours 1998 for Toledo Day Nursery

Consultant for Norvartis Pharmaceutical concerning drug Lamisil in clinical therapeutics, 1998

Consultant for Merck Pharmaceutical concerning drug Propecia in clinical therapeutics, 2001

Consultant for Medicis Pharmaceutical concerning their product line of dermatological products

Consultant for Valtrex concerning clinical therapeutics, 2001

Marketing Advisory Board for Connetics, Inc., concerning new delivery system, 1999

Advisory Board for Ferndale Laboratory concerning product line, 2002

Selected in fourth listing of ‘The Best Doctors in America’ by Woodward/White, Inc., 1998

Selected in 1999 for National Registry of Who’s Who, Life Member #53361

Reviewer for the American Hospital Formulary Service Drug Information, 1999

Interviewed on subject of head lice by various newspapers including Los Angeles Times, Chicago Tribune, and Toledo Blade

Foxington Who’s Who in Executives and Professionals, 2000 Millennium Edition

Swarthmore’s Who’s Who, 2000-2001 Millennium Edition

Included in Marquis Who’s Who in Medicine and Healthcare, 2002-3, 2004-5, 2006-7, 4th, 5th, and 6th Editions

 Dermplace@myskin> continuing Education Contest, 2nd place winner, 2001

Advisory Board of Dermatology Times, 2000-present

Part owner of Arabian horse farm with several national champions

Included in Marquis Who’s Who in Science and Engineering, 6th and 7th editions, 2002, and 2003. 

Recipient of Republican Gold Medal by Tom Davis, August 21, 2002

Contributing medical editor, Cortlandt Forum, 1999-

Earwax research featured on National Public Radio on 6/17/02 with “All Things Considered”

Nominated for the Board of Directors of the American Academy of Dermatology, 2000, 2001, 2002

Nominated for position of Assistant Secretary/Treasurer of the American Academy of Dermatology, 2002

2002 Physician of the Year by the Physicians’ Advisory Board, National Republican Congressional Committee

Listed in The Metropolitan Professional Registry, 2003.

2003 Businessman of the Year Award by the National Republican Congressional Committee

Faculty for activity workbook and CME program entitled ‘Medical Knowledge Forums in Genital Herpes: Epidemiology and Management,’ 2003

Consultant for Taro Pharmaceuticals, 2003

Listed in Consumers’ Research Council of America’s “Guide to America’s Top Physicians,” first edition, 2002-2003

Annual Reviewer for American Society of Health-System Pharmacists for topical insecticides

Included in American Hospital Formulary Service (AHFS) Drug Information Annual Reviewers List, 2003

2003 Gold Metal by Business Advisory Council of the National Republican Congressional Committee, October 7, 2003

Listed in 34th Marquis Who’s Who in Finance and Industry, 2004 thru present

Listed in Marquis Who’s Who in Medicine and Healthcare, 2004 thru present

Listed in Marquis Who’s Who in Science and Engineering, 2004 thru present

Elected to Council of the Academy of Medicine of Toledo and Lucas County, 2003

Physician of the Year Award, representing Ohio, by the Physicians’ Advisory Board, National Republican Congressional Council, 2003.

Featured Physician Profile, Dermatology Times, “Renaissance man: Ohio dermatologist fulfilled by his practice, research, writing, raising horses, family ties,” January 2004 issue

Consultant for Galderma Pharmaceutical concerning drug adapalene (differin) in clinical therapeutics, 2004

Consultant for Geigy Pharmaceuticals concerning head lice research, 2004

Consultant for Paramount ProMedica Health Systems regarding dermatological therapies for the Technology Assessment Working Group, 2004

Taro Pharmaceuticals Speakers’ Bureau, 2004-2007

National Republican Congressional Committee’s Physicians’ Advisory Board’s Pioneer of  Healthcare Reform recipient, 2004

Consultant for Dermik Pharmaceuticals concerning drug Benzaclin in clinical therapeutics, 2004

Reviewer for Pharmacist’s Letter, 2004

Reviewer for Prescriber’s Letter, 2004

The Physicians’ Advisory Board’s and the National Republican Congressional Committee’s 2004 Physician of the Year

Reviewer for American Society of Health-System Pharmacists regarding therapies for head lice, scabies, and cutaneous larvae, 2004

Editorial consultant to PIER module electronic resource website for the American College of Physicians

Semifinalist in the International Open Poetry Contest by the International Library of Poetry (www.poetry.com), February 2005

First College of Health and Human Service Distinguished Alumni Award Recipient from the University of Toledo Public Health Department, October, 2004

Consultant for the Healthcare Council at Gerson Lehrman Group, 2005-

Editor’s Choice Award for “Meditation in Art” by the International Library of Poetry at <www.poetry.com>, March 2005

Listed in ‘Guide to America’s Top Physicians’ by the Consumers’ Research Council of America, 2004-2010

Listed in 2006-7 edition thru present of Marquis Who’s Who in Medicine and Healthcare, Marquis Who’s Who in the Midwest, and Marquis Who’s Who in Science and Engineering

Won by placing in the Top Five Amateur Adult Owner to Handle, Arabian Mare Breeding Halter at the Region 14 Silverama in Lexington, Kentucky, June 29-September 3, 2005 on the horse Padrons Kham

Listed in Best Doctors in America by Best Doctors, Inc. for consecutive years 2007-2012

Listed in International Association of Dermatologists “The Leading Physicians of the World” for 2009-2010

The Phi Beta Kappa Society Honor Roll for 2000-

Member of Sarcoptes-World Molecular Network, 2010

Listed in SLD Industries, Inc. “America’s Top Dermatologist” 2010-2013

Editor-in-chief, The Open Dermatology Journal 2012-

Listed as “Leading Physician of the World” by the International Association of Dermatologists, 2015

Bronze member of Founders Guild of The Phi Beta Kappa Society


Local/National/International Presentations 

Main speaker at Medical Grand Rounds at all local hospitals as well as various other hospitals from New York to California, and Minneapolis to New Orleans 

Presentation on “Scientific evaluation of the louse sheath” at Harvard Department of Public Health, July 23, 1999.

Directed forum on “Head lice” at American Academy Meeting (national meeting) at Anaheim, California, August 1, 2001

Speaker for various pharmacological companies at various functions in both Ohio and Michigan

Speaker at Ohio Dermatology Association, American Academy of Dermatology, Michigan Dermatological Society, and Society of Investigational Dermatology 

Spoke at forum on infections and infestations at the American Academy of Dermatology National Meeting in San Francisco, March 24, 2003

Spoke on title of “Studies of oral and topical ivermectin in the treatment of head lice” at the Third International Congress of Phthiraptera at Buenos Aires, Argentina, October 17, 2006. 

Poster Sessions 

Protein Society’s Thirteenth Symposium, “Protein and Peptide Chemistry of Louse Nits” in Boston, Massachusetts, July 24-28, 1999.

American School Health Association, “National survey on head lice” in Colorado Springs, Colorado, October 9-11, 1998.

Advances in Mass Spectrometry for Genomic and Biomolecular Studies, “Mass spectrometry of head louse nits” in Orlando, Florida, January 7-8, 1999.

Annual Health Partners Research Symposium at St. Vincent Mercy Medical Center Conference, “Proteinaceous nature of the louse nit sheath” and “Cerumenolytic action of cholate and deoxycholate” in Toledo, Ohio on February 7, 2001 

National Meeting of School Nurses, “Treatment of head lice with malathion” in Cincinnati, Ohio, June 28-29, 2003.

Koka S, Kapur S, Plakkot G, Houdi M, Koka R, Kancharla P, Burkhart CG.  Usage of Artificial Intelligence powered imaging in the diagnosis of skin conditions.  American Academy of Dermatology, San Diego, California, February 25, 2024. 
 

Symposia Directorship

Co-Director on Symposium on “Medical and Veterinary Aspects of Louse Infestations” at the 3rd International Congress on Phthiraptera at Buenos Aires, Argentina, October 16-20, 2006
 

Articles 

  1. Burkhart CG.  Scabies: An epidemiological reassessment.  Annals of Internal Medicine 1983;98:498-503.
  2. Burkhart CG.  Ultrastructural study of lichen planus: An evaluation of the colloid bodies.  International Journal of Dermatology 1981;20:188-192.
  3. Burkhart CG, Mulholland M, Burnham JC.  Scanning electron microscopic evidence of bacterial overgrowth in intertrigo.  Journal of Cutaneous Pathology 1980;8:273-276.
  4. Burkhart CG, Lehmann PF.  Acne: Aspects of the immunology and microbiology.  Journal of Dermatology and Allergy 1981;4(4):23-25.
  5. Burkhart CG, Lehmann PF. Assessment of immune complexes in acne vulgaris.  British Journal of Dermatology 182;106:120-122.
  6. Burkhart CG.  A re-examination of the function of benzoyl peroxide in acne.  Journal of Dermatology and Allergy 1982;5(1):23-25.
  7. Burkhart CG, Burnham JC.  Elevated phosphorus in psoriatic skin determined by energy dispersive X-ray microanalysis.  Journal of Cutaneous Pathology 1983:10:171-177.
  8. Burkhart CG.  The lupus band test.  Ohio State Medical Journal 1980;76:290-292.
  9. Burkhart CG, Dvorak N, Stockard H. An unusual case of tinea versicolor in an immunosuppressed patient.  Cutis 1981;27:56-58.
  10. Burkhart CG.  Acquired acrodermatitis enteropathica.  Cutis 1982;27:660-661.
  11. Burkhart CG, DeStephens J.  Serum copper in herpes zoster.  Archives of Dermatology 1980;116;749.
  12. Burkhart CG.  Papular dermatographism.  International Journal of Dermatology 1980;19:562-563.
  13. Burkhart CG, DeStephens J.  Serum copper level in patients with herpes zoster.  Archives of Dermatology 1980;116:749.
  14. Burkhart CG.  Pitted keratolysis: A new therapeutic treatment.  Archives of Dermatology 1980;116:1104.
  15. Burkhart CG, Smith MR.  Erythema multiforme following X-ray therapy.  Journal of the American Academy of Dermatology 1980;3:94-96.
  16. Burkhart CG.  Hair changes in acrodermatitis enteropathica.  Archives of Dermatology 1980;116:384.
  17. Burkhart CG, Shapiro R.  Pseudomonas folliculitis: Development after the home use of personal whirlpool spa.  Cutis 1980;25:642-643.
  18. Burkhart CG.  Insect allergy: Short synopsis of recent developments.  International Journal of Dermatology 1980;19:388-389.
  19. Burkhart CG, Bhumbra R, Iannone AM.  Nail-patella syndrome: A distinctive clinical and electron microscopic presentation.  Journal of the American Academy of Dermatology 1980;3:251-256.
  20. Burkhart CG.  Beau’s lines: An association with pustular psoriasis and telogen effluvian.  Archives of Dermatology 1980;116:1190-1191.
  21. Burkhart CG.  Hydrocortisone for pruritis ani.  Schoch Letter 1980;30:9.
  22. Burkhart CG.  Familial diffuse keratoderma.  Journal of Dermatology and Allergy 1980;3(8):27-28.
  23. Burkhart CG.  Treatment of psoriasis with methotrexate and folinic acid.  Journal of the American Academy of Dermatology 1980;3:207-208.
  24. Burkhart CG.  Incontinentia pigmenti achromians.  Journal of Dermatology and Allergy 1980;3(7):40-42.
  25. Burkhart CG.  Guttate psoriasis.  Journal of Dermatology and Allergy 1980;3(9):25-28.
  26. Burkhart CG.  Erythema infectiosum: Fifth disease.  Journal of Dermatology and Allergy 1980;3(8):50-52.
  27. Ballas PG, Burkhart CG.  Differential diagnosis and work-up of pruritus.  Journal of Dermatology and Allergy 1980;3(9):14-16.
  28. Burkhart CG, DeStephens J.  Disseminated herpes zoster: A rapid diagnostic test using electron microscopy.  Cutis 1980;26:524-525.
  29. Burkhart CG, Gohara A.  Dermal melanocyte hamartoma: A distinctive new form of dermal melanocytosis.  Archives of Dermatology 1981;117:102-104.
  30. Burkhart CG.  Pustular allergic contact dermatitis: A distinctive clinical and pathological entity.  Cutis 1981:27:630-638.
  31. Burkhart CG, El-Shaar A.  Computerized axial tomography in the early diagnosis of tuberous sclerosis.  Journal of the American Academy of Dermatology 1981;4:59-63.
  32. Burkhart CG. Dermatological lesions of the eyelid. Modern Medicine 1981;49:102-108.
  33. Burkhart CG.  Perforating folliculitis: A reappraisal of its pathogenesis.  International Journal of Dermatology 1981;20:59-599.
  34. Burkhart CG.  Looking at eyelid lesions – a clinical round up.  Geriatrics.  1981;36:91-95.
  35. Burkhart CG.  A beginning editorial.  Journal of Dermatology and Allergy 1980;3(9):13.
  36. Burkhart CG.  Cost containment: A vote for the voluntary effort.  Journal of Dermatology and Allergy 1980;3(10):9.
  37. Burkhart CG.  A positive vote for over-the-counter hydrocortisone.  Journal of Dermatology and Allergy 1980;3(11):9.
  38. Burkhart CG.  Dermatologist of the Year Award.  Journal of Dermatology and Allergy 1980;3(12):9.
  39. Burkhart CG.  Sweaty sock dermatitis.  Journal of Dermatology and Allergy 1980;3(11):29-31.
  40. Ragan C, Woods S, Lindstrom CJ, Burkhart CG.  Improving the rate of kept appointments at outpatient clinics.  Journal of Dermatology and Allergy 1980;3(12):22-24.
  41. Burkhart CG.  Two forms of benign adolescent purpura.  Journal of Dermatology and Allergy 1980;3(12):44-45.
  42. Burkhart CG, McLeish KR, Caldwell C, Ribner B, Alousi MA, O’Donnell E.  Cryptococcosis.  Journal of Dermatology and Allergy 1980;3(11):10-19.
  43. Burkhart CG.  Advertising in medicine.  Journal of Dermatology and Allergy 198a;4(1):2.
  44. Burkhart CG.  Nail-patella syndrome.  Journal of Dermatology and Allergy 1981;4(1):33-36.
  45. Burkhart CG.  Initial therapy for acne.  Journal of Dermatology and Allergy 1981;4(1):43-48.
  46. Burkhart CG.  Surgical treatment of angiomas.  Journal of Military Dermatology 1981:7(2):12-14.
  47. Burkhart CG.  Who policies health-related advertisements?  Journal of Dermatology and Allergy 1981;4(2):13-14.
  48. Burkhart CG.  Geographic tongue.  Journal of Dermatology and Allergy 1981;4(2):35.
  49. Burkhart CG.    Erythema annulare centrifugum: A case due to tuberculosis.  International Journal of Dermatology 1982;21:538-539.
  50. Burkhart CG.  Stevens-Johnson Syndrome.  Journal of Cutaneous Adolescent Medicine 1981;3(2):16-19.
  51. Burkhart CG.  Persistent cutaneous herpes simplex infection.  International Journal of Dermatology 1981;20:552-554.
  52. Burkhart CG.  Drug-induced acne.  Journal of Dermatology and Allergy 1981;4(3):27-30.
  53. Burkhart CG.  Solutions to policing deceptive health-related advertising.  Journal of Dermatology and Allergy 1981;4(3):17-18.
  54. Burkhart CG.  Tinea incognito.  Archives of Dermatology 1981;117:606-607.
  55. Burkhart CG.  Psychocutaneous disorders of the skin.  Journal of Dermatology and Allergy 1982;5(4):47-48.
  56. Burkhart CG.  Poetry for the New Year.  Journal of Dermatology and Allergy 1981;4(4):2-4.
  57. Burkhart CG.  Questions on health care.  Journal of Dermatology and Allergy 1981;4(5):2-3.
  58. Burkhart CG.  Reticulated purpura accompanying venous insufficiency of the lower extremities.  Journal of Dermatology and Allergy 1981;4(5):54-55.
  59. Burkhart CG.  Finger pulp dermatitis.  Journal of Dermatology and Allergy 1981;4(5):60-61.
  60. Burkhart CG, Ruppert ES.  Dystrophic epidermolysis bullosa: A sporadic case of the dominant form.  Clinical Pediatrics 1981;20:493-496.
  61. Burkhart CG.  Baldness: The catastrophic event of my life.  Ohio Medical Journal 1981;77:483-485.
  62. Burkhart CG.  Cost of medical technology.  Journal of Dermatology and Allergy 1981;4(6):8.
  63. Burkhart CG.  Roseola infantum.  Journal of Dermatology and Allergy 1981;4(6):49-50.
  64. Burkhart CG.  Peutz-Jeghers Syndrome.  Journal of Dermatology and Allergy 1981;4(6):50-51.
  65. Burkhart CG.  Medical research and education: Charity or social investment.  Journal of Dermatology and Allergy 1981;4(7):3.
  66. Burkhart CG.  Letterer-Siwe Disease.  Journal of Dermatology and Allergy 1981;4(7):41-42.
  67. Burkhart CG.  Keratosis punctata.  Journal of Dermatology and Allergy 1981;4(7):44-45.
  68. Burkhart CG.   The American physician.  Journal of Dermatology and Allergy 1981;4(8):9-10.
  69. Burkhart CG.  Monilethrix.  Journal of Dermatology and Allergy 1981;4(8):11-12.
  70. Burkhart CG, Huttner J, Brunner J.  Central trichoptilosis.  Journal of American Academy of Dermatology 1981;5:703-705.
  71. Burkhart CG.  Allied health practitioners: A challenge to the present health care delivery system.  Journal of Dermatology and Allergy 1981;4(9):9-10.
  72. Burkhart CG.  Mastocytomas.  Journal of Dermatology and Allergy 1981;4(9):11-12.
  73. Burkhart CG.  The American nursing dilemma.  Journal of Dermatology and Allergy 1981;4(10):3-4.
  74. Burkhart CG.  Lymphangitis.  Journal of Dermatology and Allergy 1981;4(10):20-21.
  75. Burkhart CG.  Post inflammatory hyperpigmentation.  Journal of Dermatology and Allergy 181;4(10):21-22.
  76. Burkhart CG.  Quinidine-induced acne.  Archives of Dermatology 1981;117:603-604.
  77. Burkhart CG.  Decreasing patient no-shows. Physician’s Management 1981;10:14-15.
  78. Burkhart CG.  Anetoderma.  Journal of Dermatology and Allergy 1981;4(11):49-50.
  79. Burkhart CG.  Pruritic urticarial papules and plaques of pregnancy.  Journal of Dermatology and Allergy 1981;4(11):42-43.
  80. Burkhart CG.  Hospitals and outpatient medical care in the 1980’s.  Journal of Dermatology and Allergy 1981;4(11):13-14.
  81. Burkhart CG.  Benign mastocytomas.  Archives of Dermatology 1982;118:449-450.
  82. Burkhart CG.  Christmas song.  Journal of Dermatology and Allergy 1981;4(12):8.
  83. Burkhart CG.  Focal dermal hypoplasia (Goltz’s Syndrome).  Journal of Dermatology and Allergy 1981;4(12):36-38.
  84. Burkhart CG.  Cutaneous calcifications in acute renal failure.  Journal of Dermatology and Allergy 1981;4(12):44-45.
  85. Burkhart CG.  Pyridoxine-responsive herpes gestationis.  Archives of Dermatology 1982;118;535.
  86. Burkhart CG.  The American patient.  Journal of Dermatology and Allergy 1982;5(1):49.
  87. Burkhart CG.  Hereditary keratosis of palms and plantar surfaces: An ectodermal dysplasia.  Journal of Dermatology and Allergy 1982;5(1):8-10.
  88. Burkhart CG.  Lymphangitis: Editor’s reply.  Journal of Dermatology and Allergy 1982;5(1):21.
  89. Burkhart CG.  Lymphedema.  Journal of Dermatology and Allergy 1982;5(1):30-31.
  90. Burkhart CG.  Dermatology house calls-I.  Journal of Dermatology and Allergy 1980;3(10):28-29.
  91. Burkhart CG.  Dermatology house calls-II.  Journal of Dermatology and Allergy 1980;3(1):40-41.
  92. Burkhart CG.  Dermatology house calls-III.  Journal of Dermatology and Allergy 1981;4(1):50-51.
  93. Burkhart CG.  Dermatology house calls-IV.  Journal of Dermatology and Allergy 1981;4(2):26-27.
  94. Burkhart CG.  Prevention.  Journal of Dermatology and Allergy 1982;5(2):7.
  95. Burkhart CG.  Dandruff.  Journal of Dermatology and Allergy 1982;5(2):30-32.
  96. Burkhart CG.  Pearly penile papules.  Journal of Dermatology and Allergy 1982;5(4):36-37.
  97. Burkhart CG.  Tinea versicolor.  Journal of Dermatology and Allergy 1983;6(1):8-10.
  98. Burkhart CG.  Granuloma infantum.  Journal of Dermatology and Allergy 1982;5(6):23-24.
  99. Burkhart CG.  Job’s syndrome, hidradentitis suppurtiva and acne.  Journal of Dermatology and Allergy 1983;6(3):38-40.
  100. Arrowsmith JN, Burkhart CG.  Treatment of acne with oral tetracycline: Efficacy and safety.  Journal of Dermatology and Allergy 1983;7(1):15-17.
  101. Koehler TP, Morrow LB, Burkhart CG.  Irradiation and acne: Mechanism of action, indications, and suggested follow-up.  Journal of Dermatology and Allergy 1983;6(2):16-18.
  102. Brinker D, Burkhart CG.  Side effects of topical steroids.  Journal of Dermatology and Allergy 1982;5(6):24-26.
  103. Burkhart CG.  Hirsutism:  Editor’s note.  Journal of Dermatology and Allergy 1982;5(4):17-18.
  104. Burkhart CG, Rower JM.  Eosinophilic papular eruption of African Americans.  Journal of Dermatology and Allergy 1982;5(4):12-13.
  105. Grayson DJ, Burkhart CG.  A review of therapy in managing psoriasis.  Journal of Dermatology and Allergy 1982;5(12):43-48.
  106. Krister LE, Burkhart CG.  Growth patterns in medial practice.  Journal of Dermatology and Allergy 1982;5(5):22.
  107. Krister LE, Burkhart CG.  Physicians’ incomes, expenses, and fees 1970-1980. Journal of Dermatology and Allergy 1983;6(1):27-28.
  108. Krister LE, Burkhart CG.  Physicians’ work patterns.  Journal of Dermatology and Allergy1982;5(6):30.
  109. Burkhart CG.  Continuing medical education: Boon and boondoggle.  Journal of Dermatology and Allergy 1982;5(12):3.
  110. Mishlove LR, Burkhart CG.  Malignant melanoma.  Journal of Dermatology and Allergy 1982;5(5):20-22.
  111. Luppino M, Burkhart CG.  Seborrheic dermatitis.  Journal of Dermatology and Allergy 1982;5(7):28-29.
  112. Burkhart CG.  Collection of one-liners.  Journal of Dermatology and Allergy 1982;5(4):5-6.
  113. Burkhart CG.  The dermatologist.  Journal of Dermatology and Allergy 1982;5(10):7-8.
  114. Burkhart CG.  Cost containment: A survey of the issue.  Journal of Dermatology and Allergy 1982;5(5):9.
  115. Burkhart CG.  Modalities of teaching cost containment.  Journal of Dermatology and Allergy 1982;5(7):1-2.
  116. Burkhart CG.  Cost containment in medical education.  Journal of Dermatology and Allergy 1982;5(6):1-2.
  117. Burkhart CG.  Future directions in cost containment.  Journal of Dermatology and Allergy 1982;5(8):1-2.
  118. Collins T, Burkhart CG.  Clubbing.  Journal of Dermatology and Allergy 1983;6(1);9-10.
  119. Collins T, Burkhart CG.  Diagonal earlobe crease and coronary artery disease.  Journal of Dermatology and Allergy 1982;5(6):31-32.
  120. Krajcik R, Burkhart CG.  Scabies: A clinical review.  Journal of Dermatology and Allergy 1982;5(3):22-25.
  121. Burkhart CG.  Practitioner’s disease.  Journal of Dermatology and Allergy 1982;5(3):1.
  122. Gulyas CE, Burkhart CG.  Molluscum contagiosum.  Journal of Dermatology and Allergy 1982;5(3):1.
  123. Burkhart CG.  Management of peristomal skin: Editor’s note.  Journal of Dermatology and Allergy 1982;5(9):20.
  124. Burkhart CG.  Piezogenic pedal papules.  Journal of Dermatology and Allergy 1983;6(2):25-26.
  125. Burkhart AK, Burkhart CG.  Professional attitudes on health care costs.  Ohio State Medical Journal 1982;78:829-830.
  126. Burkhart AK, Burkhart CG.  Professional attitudes on American lifestyles.  Ohio State Medical Journal 1982;78:823-825.
  127. Burkhart CG.  Herpes virus infections.  Journal of Dermatology and Allergy 1982;5(7):16-19.
  128. Stierwalt RJ, Burkhart CG.  Pityriasis rosea: Update.  Journal of Dermatology and Allergy 1982;5(10):23-24.
  129. Burkhart AK, Burkhart CG.  Foreign conventions: New tax legislation.  Journal of Dermatology and Allergy 1982;5(2):32.
  130. Burkhart CG.  Goltz’s syndrome and wound healing.  Archives of Dermatology 1983;119:187.
  131. Burkhart CG, Price J.  A survey of college students on the subject of acne.  Journal of Dermatology and Allergy 1983;6(5):20-26.
  132. Burkhart CG.  Exfoliative dermatitis.  Hospital Medicine 1983;20:139-153.
  133. Burkhart CG. Business as usual.  Journal of Dermatology and Allergy 1982;5(11):13.
  134. Burkhart CG.  Truth-telling to patients.  Journal of Dermatology and Allergy 1983;6(1):6.
  135. Burkhart CG.  Truth-telling to patients: Part 2. The physician-patient relationship.  Journal of Dermatology and Allergy 1983;6(2):6-7.
  136. Burkhart CG.  Truth-telling to patients: Part 3. Journal of Dermatology and Allergy 1983;6(3):7-8.
  137. Wehrmeister J, Burkhart CG.  Chronic urticaria: Current modes of therapy.  Journal of Dermatology and Allergy 1983;6(3):21-24.
  138. Shore RN, Burkhart CG.  Alternative antibiotics in the treatment of acne vulgaris: Part 1. Cephalosporins.  Journal of Dermatology and Allergy 1983;6(3):28-29.
  139. Shore RN, Burkhart CG.  Alternative antibiotics in the treatment of acne vulgaris: Part 2. Ampicillin – a first-line drug in the treatment of acne.  Journal of Dermatology and Allergy 1983;6(4):45-48.
  140. Burkhart CG.  Food allergy and urticaria.  Journal of Dermatology and Allergy 1983;6(4):29-32.
  141. Burkhart CG.  The acne diet needs more testing.  Journal of Dermatology and Allergy 1983;6(5):9.
  142. Burkhart CG.  The collective voice of physicians.  Journal of Dermatology and Allergy 1983;6(7):8.
  143. Burkhart CG.  Normal hair findings in neonatal copper deficiency.  Journal of Dermatology and Allergy 1983;6(7):13-14.
  144. Burkhart CG.  Health fitness and industry.  Journal of Dermatology and Allergy 1983;6(8):8.
  145. Burkhart CG.  Skin diseases caused by arthropods.  Journal of Dermatology and Allergy 183;6(8):9-15.
  146. Burkhart CG.  Stinging insect allergy.  Journal of Dermatology and Allergy 1983;6(8):46-47.
  147. Burkhart CG.  Piezogenic pedal papules.  Cutis 1984;34:70.
  148. Smith A, Burkhart CG.  Pruritus of pregnancy.  Cutis 1984;34:486-488.
  149. Burkhart CG.  Are city sun parlor ordinances necessary?  Ohio State Medical Journal 1991;87:428-429.
  150. Burkhart CG.  Pentoxifylline for Schamberg’s Disease.  Journal of the American Academy of Dermatology 1998;39:298.
  151. Burkhart CG.  Family physicians discuss dermatological training.  Archives of Dermatology 1998;34:634.
  152. Burkhart CG.  What’s good for a horse: Ivermectin therapy in Haiti.  Skin and Allergy News 1998;29(2):17.
  153. Burkhart KM, Burkhart CG.  Food and Drug Administration puts lid on Skin-cap.  Postgraduate Medicine 997;102:23.
  154. Burkhart CG.  Cutaneous problems of the foot in recreational sports activities.  The Physician and Sportsmedicine 1999;27(2):88-101.
  155. Burkhart CG, Burkhart KM, Burkhart AK.  The Physicians’ Desk Reference should not be held as a legal standard of medical care.  Archives of Pediatrics and Adolescent Medicine 1998;152:609-610.
  156. Burkhart CG.  Practice Pearls: Office brochures.  Dermatology Times 1998;19(2):43.
  157. Burkhart CG.  The fungal fallacy uncovered.  Journal of Clinical Dermatology 1999;2(3):8-9.
  158. Burkhart CG.  A second vote for terbenifine for tinea capitis.  Dermatology Times 1998;19(8):3.
  159. Burkhart CG.  Espresso, latte, and lamisil.  Skin and Allergy News 1998;29(8):11.
  160. Burkhart CG, Butcher C, Cantril J, Lehmann P.  Propionibacterium acnes: Interaction with complement and development of an enzyme-linked immunoassay for the detection of antibody.  International Journal of Dermatology 1999;38:200-203.
  161. Burkhart CG.  Medicine that’s easier to swallow.  Postgraduate Medicine 1998;104(3):40.
  162. Burkhart CG.  Physicians should treat head lice.  Infections in Medicine 1999;16(2):97.
  163. Burkhart CG.  Dermatology Diagnosis: Stevens-Johnson Syndrome.  Cortlandt Forum 1999;12(5):154-157.
  164. Burkhart CG.  Dermatology Diagnosis: Pruritic urticarial papules and plaques of pregnancy.  Cortlandt Forum 1999;12(8):63-64.
  165. Burkhart CG.  Improving the rate of kept appointments at dermatology clinics.  Journal of the American Academy of Dermatology 2001;44:313-314.
  166. Burkhart CG.  Propionibacterium acnes products seen as instigator: Organism excretes several extra cellular components, which lead to inflammation.  Dermatology Times 1999;20(9):S17-18.
  167. Burkhart CG, Burkhart KM.  Superficial fungal infections in horses treated with terbinafine.  Journal of Equine Veterinary Science 1999;19:652-653.
  168. Burkhart CG.  Dermatology Diagnosis: Sweaty sock dermatitis.  Cortlandt Forum 1000;13(1):180-183.
  169. Burkhart CG.  Dermatology Diagnosis: Tinea versicolor.  Cortlandt Forum 2000;13(2):43-44.
  170. Burkhart CG.  Dermatology Diagnosis: Congenital lymphedema: A gradually swelling leg.  Cortlandt Forum 1999;12(12):189-190.
  171. Burkhart CG.  Research would cure ‘Thrill is gone syndrome.’ Dermatology Times 1999;20(10):5.
  172. Burkhart CG.  Responses to the fungal fallacy.  Journal of Clinical Dermatology 199;2(4):6-10.
  173. Burkhart CG.  Coffee grinders assist pediatric dosing.  Cutis 2000;65:276.
  174. Burkhart CG.  Questioning terbinafine’s role in tinea versicolor.  Skin and Aging.  1999;7(11):19-20.
  175. Burkhart CG.  Clinical Corner: Physicians’ Desk Reference as legal standard.  Legaline 2000;1:2.
  176. Burkhart CG.  Lymphedema.  Clinical Advisor 2000;3(4):109-110.
  177. Burkhart CG.  Dermatology Diagnosis: Cough purpura.  Cortlandt Forum 2000;13(5):179-180.
  178. Burkhart CG.  Dermatology Diagnosis: Acne excoriee: Saving face. Cortlandt Forum 2000;13(7):181-185.
  179. Burkhart CG.  Dermatology Diagnosis: Periodic back blister – herpes simplex.  Cortlandt Forum 2000:13(7):181-182.
  180. Burkhart CG.  Dermatology Diagnosis: Benign migratory glossitis.  Cortlandt Forum 2000;13(6):43-47.
  181. Burkhart CG, Burkhart KM.  Perspectives concerning genital herpes.  Infections in Medicine 1999;16(8):525-528.
  182. Burkhart CG.  Response to letters to the editor concerning genital herpes.  Infections in Medicine 2000;17:378-379.
  183. Burkhart CG.  How to cope with genital herpes.  Consultant: Consultations in Primary Care 200;40:1298-1301.
  184. Burkhart CG.  Dermatology Diagnosis: Nail-patella syndrome. Cortlandt Forum 2001;14(11):25-26.
  185. Burkhart CG.  Raising a few questions about the ramifications of recertification.  Dermatology Times 2000;21(7):5.
  186. Burkhart CG.  Dermatology Diagnosis: Molluscum contagiosum.  Cortlandt Forum 2000;13(9):37-38.
  187. Burkhart CG.  Primary Care Update: How to cope with genital herpes.  Consultant 2000;40:1298-1301.
  188. Burkhart CG.  A profusion of macules: Tinea versicolor. Cortlandt Forum 2000;3(10):28-31.
  189. Burkhart CG.  Can antibiotic use increase skin cancer risk?  Skin and Aging 2000;8(11):16.
  190. Burkhart CG.  Dermatology Diagnosis: Fingertip dermatitis.  Cortlandt Forum 2000;13(11):35-39.
  191. Burkhart CG.  Dermatology Clinic: Painful feet.  Clinical Advisor 2000;3(12):38-41.
  192. Burkhart CG.  Dermatology Clinic: Concern over freckles – Peutz-Jeghers Syndrome. Cortlandt Forum 2001;14(2):25-26.
  193. Burkhart CG.  Consider the Physicians’ Desk Reference a reference source, not a legal standard.  Dermatology Times 2001;22(5):4-5.
  194. Burkhart CN, Stankiewicz BA, Pchalek I, Kruge MA, Burkhart CG.  Molecular composition of the louse sheath.  Journal of Parasitology 1999;85:559-561.
  195.  Burkhart CN, Burkhart CG, Pchalek I, Arbogast J.  The adherent cylindrical nit structure and its chemical denaturation in vitro: An assessment with therapeutic implications for head lice.  Archives of Pediatrics and Adolescent Medicine 1998;152:711-712.
  196. Burkhart CN, Burkhart CG.  Lice:  The spectrum of disease in animal and man with special emphasis on whether head lice are possible vectors for systemic infections.  Journal of Clinical Dermatology 1998;1(3):10-14.
  197. Burkhart CN, Burkhart CG.  Odds and ends of head lice: Characteristics, risk of fomite transmission, and treatment.  Journal of Clinical Dermatology 1999;2(2):15-18.
  198. Burkhart CN, Burkhart CG, Gunning WT, Arbogast J.  Scanning electron microscopy of the egg of the human head louse (Anoplura: Pediculus humanus capitis) with clinical ramification.  Journal of Medical Entomology 1999;36:454-456.
  199. Price JH, Burkhart CN, Burkhart CG.   School nurses’ perceptions of and experiences with head lice.  Journal of School Health 1999;69:153-158.
  200. Burkhart CN, Burkhart CG.  Another look at ivermectin in the treatment of scabies and head lice.  International Journal of Dermatology 1999;38:235-236.
  201. Burkhart KM, Burkhart CN, Burkhart CG.  Update on therapy: Ivermectin is available for use against lice.  Infections in Medicine 1997;14:689.
  202. Burkhart KM, Burkhart CN, Burkhart CG.  Our scabies treatment is archaic – but ivermectin has arrived.  International Journal of Dermatology 1998;37:76-77.
  203. Burkhart KM, Burkhart CN, Burkhart CG.  Comparing topical scabietic treatments will soon become extinct.  Archives of Dermatology 1997;133:1314.
  204. Burkhart CG, Burkhart CN.  An assessment of the topical and oral, prescription and over-the-counter treatments for head lice.  Journal of the American Academy of Dermatology 1998;38:979-982.
  205. Burkhart CN, Burkhart CG.  Bitter pill for lice.  Skin and Allergy News 1998;29(1):10.
  206. Burkhart KM, Burkhart CN, Burkhart CG.  Ivermectin: An alternative treatment for scabies.  Skin and Aging 1998;6(2):46.
  207. Burkhart CG, Burkhart CN.  Tazarotene gel for Darier’s Disease.  Journal of the American Academy of Dermatology 19998;38:1001-1002.
  208. Burkhart CG, Burkhart CN, Burkhart KM.  An epidemiologic and therapeutic reassessment of scabies: Special focus on fomite transmission and the newly available ivermectin oral treatment.  Cutis 2000;65:233-240.
  209. Burkhart CN, Burkhart CG, Arbogast J.  Lice don’t like pomades: Non-insecticidal therapies for head lice.  Skin and Allergy News 1998;29(4):13.
  210. Burkhart CN, Burkhart CG, Arbogast J.  Head lice therapy revisited.  Clinical Pediatrics 1998;37:395.
  211. Burkhart CG, Burkhart CN.  Acne Keloidalis: Lichen simplex chronicus with fibrotic keloidal scarring. Journal of the American Academy of Dermatology 1998;39:661.
  212. Burkhart CG, Burkhart CN.  Imiquimod as adjunct for vitiligo.  Journal of Clinical Dermatology 1998;1(3):6-9.
  213. Burkhart CN, Burkhart CG.  Ivermectin:  A few caveats are warranted before initiating therapy for scabies.  Archives of Dermatology 1999;135:1549-1550.
  214. Burkhart CG, Burkhart CN.  Scabies in nursing homes: Focus on oral ivermectin therapy.  Journal of Clinical Dermatology 1998;1(4):31-33.
  215. Burkhart CG, Burkhart CN.  Ivermectin safety concerns.  Skin and Allergy News 19998;29(10):24.
  216. Burkhart CG, Burkhart CN, Jutila S, Gottwald L.  Pemphigoid precipitated by magnetic mattress: Query if electromagnetic fields cause cutaneous disease? Journal of Clinical Dermatology 199;2(1):6.
  217. Burkhart CG.  Questioning terbinafine’s role in tinea versicolor.  Skin and Aging 1999;5(11):19-20.
  218. Burkhart CG, Burkhart CN.  Ivermectin for cutaneous larvae migrans (letter). Cutis 1998;62:170.
  219. Burkhart CG, Burkhart CN.  Phenylalanine with UVA for the treatment of vitiligo needs more testing for possible side effects.  Journal of the American Academy of Dermatology 199;40:1015.
  220. Burkhart CG, Burkhart CN, Lehmann PL.  Acne: A review of immunologic and microbiologic factors.  Postgraduate Medical Journal 1999;75:328-331.
  221. Burkhart CG, Burkhart CN, Mian A.  Calciphylaxis:  A case report and review of literature.  Wounds:  A Compendium of Clinical Research and Practice 1999;11(2):63-66.
  222. Burkhart CN, Burkhart CG.  Dermatologists note discrepancies in article about lice.  Dermatology Times 1999;20(3):3.
  223. Burkhart CN, Burkhart CG. Return to the case of the silent meringue: Crab lice.  Infections in Medicine 1999;16:182.
  224. Burkhart CN, Arbogast J, Smythe P, Burkhart CG.  Histochemical analysis of the nit of Pediculus humanus capitis.  Journal of Medical Entomology 1999;36:530-532.
  225. Burkhart CN, Arbogast J, Gunning WT, Adappa V, Burkhart CG.  Asperigillosis flavus isolated in cerumen by scanning electron microscopy.  Infections in Medicine 2000;17(9):624-626.
  226. Burkhart CG.  Dermatology Clinic: Molluscum contagiosum.  Clinical Advisor 2001;10(6):33-34.
  227. Burkhart CG, Burkhart CN.  Melanoma and insecticides: Is there a connection?  Journal of the American Academy of Dermatology 2000;42:302-303.
  228. Burkhart CN, Burkhart CG.  Oral ivermectin therapy for Phthiriasis palpebrum.  Archives of Ophthalmology 2000;118:134-135.
  229. Burkhart CN, Burkhart CG.  Before using ivermectin therapy for scabies.  Pediatric Dermatology 1999;16:478-480.
  230. Burkhart CG.  Questioning terbinafine’s role in tinea versicolor.  Skin and Aging 1999;7(11):19-20.
  231. Burkhart CN, Burkhart CG, Williams S, Andrews PC, Adappa V, Arbogast J.  In pursuit of ceruminolytic agents: A study of earwax composition.  American Journal of Otology 2000;21:157-160.
  232. Burkhart CN, Gunning WT, Burkhart CG.  Scanning electron microscopic examination of the egg of the pubic louse (Anoplura: Pthirus pubis).  International Journal of Dermatology 2000;39:201-202.
  233. Burkhart CG, Burkhart CN.  Use of topical nicotine for treatment of Pediculus humanus capitis (Anoplura: Pediculidae).  Journal of Medical Entomology 2000;37:170-171.
  234. Burkhart CN, Burkhart CG.  Route of head lice transmission needs enlightenment for proper epidemiological evaluations.  International Journal of Dermatology 2000;39:878-879.
  235. Burkhart CG, Butcher C, Burkhart CN, Lehmann PF.  Effects of benzoyl peroxide on lipogenesis in sebaceous glands using animal model.  Journal of Cutaneous Medicine and Surgery 2000;4:138-141.
  236. Burkhart CN, Burkhart CG.  Malathion for head lice.  Cutis 1999;64:314.
  237. Burkhart CN, Gunning WT, Burkhart CG.  Scanning electron microscopy of adult head lice (Pediculus humanus capitis) with focus on clinical implications. Journal of Cutaneous Medicine and Surgery 2000;4:181-185.
  238. Burkhart CG, Burkhart CN.  Clinical evidence of lice resistance to over-the-counter products.  Journal of Cutaneous Medicine and Surgery 2000;4:199-201.
  239. Burkhart CG, Burkhart CN.  Magnets for the treatment of chronic back pain.  Journal of the American Medical Association 2000;284:564-566.
  240. Burkhart CG.  Artificial nail ban.  Cosmetic Dermatology 2001;14(5):27.
  241. Burkhart CG.  Dermatology Forum: Painful palms of keratosis punctata.  Cortlandt Forum 2001;14(10):27-28.
  242. Burkhart CN, Burkhart CG.  Recommendation to standardize pediculicidal and ovicidal testing for head lice (Anoplura: Pediculidae).  Journal of Medical Entomology 2001;38:127-129.
  243. Burkhart CG, Burkhart CN.  Assessment of sunscreens with patient care consideration. Cosmetic Dermatology 2001;14(5):21-22.
  244. Burkhart CG, Burkhart CN.  Propionibacterium acnes:  An indigenous bacteria may be pathogenic in several cutaneous disease states.  Archives of Dermatology 2001;137:1250.
  245. Burkhart CG, Burkhart CN.  Optimal treatment for scabies remains undetermined.  Journal of the American Academy of Dermatology 2001;45:637-8.
  246. Burkhart CG.  Dermatologists headed for ‘lousy’ problem.  Dermatology Times 2001;22(11):19.
  247. Burkhart CG.  Artificial nail ban.  Cosmetic Dermatology 2001;6:27. 
  248. Burkhart CN, Burkhart CG.  Tensegrity as a factor in cutaneous disease.  Cosmetic Dermatology 2001;14(7):65-66.
  249. Burkhart CG.  Can antibiotic use increase skin cancer risk?  Skin and Aging 2000;3(11):16.
  250. Burkhart CG.  Dermatology Forum:  Blistering baby (epidermolysis bullosa).  Cortlandt Forum 2001;15(1):27-28.
  251. Burkhart CG, Burkhart CN.  Azithromycin and hearing loss.  Dermatology Times 2001;22(9):4.
  252. Burkhart CG.  Brushing through ten points about finasteride.  Cosmetic Dermatology 2001;14(9):12.
  253. Burkhart CG, Burkhart CN.  Overplaying the dark side of tanning.  Cosmetic Dermatology 2001;14(10):12.
  254. Burkhart CG.  Dermatology Diagnosis: Whirlpool folliculitis. Cortlandt Forum 2002;15(2):28-31.
  255. Burkhart CG.  Dermatology Diagnosis: Scabies. Cortlandt Forum 2002;15(4):34-37.
  256. Burkhart CN, Kruge MA, Burkhart CG, Black C. Cerumen composition by flash pyrolysis-gas chromatography/mass spectrometry.  Journal of Otology and Neurotology 2001;22:715-722.
  257. Burkhart CG, Burkhart CN.  Topical pyrethroids: assessment for function and efficacy in head lice.  International Pediatrics 2002;17:209-212.
  258. Burkhart CG, Burkhart CN.  The use of nicotine in dermatology revisited.  International Journal of Dermatology 2001;40:731-2.
  259. Burkhart CG.  Dermatology Clinic: Palmar lesions.  Clinical Advisor 2002;5(3):94-97.
  260. Burkhart CG.  Dermatology Diagnosis: Not on the growth charts (Mastocytoma).  Cortlandt Forum 2002;15(6):28-33.
  261. Burkhart CG, Burkhart CN.  Estrogenic activity in organic sunscreens.  Cosmetic Dermatology 2001;14(11):15.
  262. Burkhart, CG.  Add sucralfate to list of aphthous ulcer treatments.  Cutis 2002;70:275.
  263. Burkhart CG.  Management of tinea gladiatorum.  Journal of the American Academy of Dermatology 2002;46:e4.
  264. Burkhart CN, Burkhart CG.  Reassessment of diclofenac/hyaluronan gel for actinic keratoses.  International Journal of Dermatology 2002;41:371-2.
  265. Burkhart CN, Burkhart CG, Gupta AK.  Dermatophytoma: recalcitrance to treatment due to fungal biofilm.  Journal of American Academy of Dermatology 2002;47:629-631
  266. Burkhart CG.  Dermatology Clinics: Acne Excoriee.  Clinical Advisor 2002;5(5):31-32.
  267. Meinking TL, Burkhart CG, Burkhart CN.  Head lice.  New England Journal of Medicine 2002;347:1381-1382.
  268. Burkhart CG.  Dermatology Clinics: Scabies.  Clinical Advisor 2002;5(7):76-79.
  269. Burkhart CG.  Dermatology Clinics: Herpes simplex.  Clinical Advisor 2002;5(9):23-24.
  270. Burkhart CN, Burkhart CG.  Use of topical immunomodulators with 5-fluorouracil.  Journal of Drugs in Dermatology 2002;1:122-123.
  271. Burkhart CG.  Drug samples: Friend or foe.  Journal of Drugs in Dermatology 2002;1:123-124.
  272. Burkhart CG.  Dermatology Clinic: Peutz-Jeghers Syndrome.  Clinical Advisor 2002;5(11/12):27-28.
  273. Burkhart CG.  Losing lindane: Troubled treatment, banned in California, gets slap from FDA for adverse effects.  Dermatology Times 2003;24(4):1-2.
  274. Burkhart CG.  Ivermectin: treatment of choice for scabies and maybe lice, too.  Infectious Disease News 2003;16(6):29-30.
  275. Burkhart CN, Burkhart CG.  Antibiotic resistant Propionibacterium  acnes may not be the major issue clinically or microbiologically in acne.  British Journal of Dermatology 2003;148:365-7.
  276. Burkhart, CG.  Dysplastic nevus declassified: Even the NIH recommends elimination of confusing terminology.  Skin Med: Dermatology for the Clinician 2003;2(1):12-13.
  277. Burkhart CG, Gunning WT.  School rash syndrome: The experience in Northwest Ohio.  Skin Med: Dermatology for the Clinician 2002;1:91-93.
  278. Burkhart CG.  Infections of the skin: Ivermectin safe, effective in treating scabies, maybe head lice.  Infectious Disease News 2003;16(6):1.
  279. Burkhart CG, Burkhart CN. Swimmer's itch: An assessment proposing possible treatment with ivermectin.  International Journal of Dermatology 2003;42:917-8.
  280. Burkhart CG, Burkhart HR.  Contact irritant dermatitis and the anti-pruritic agents: the need to address the itch. Journal of Drugs in Dermatology 2003;2:143-146.
  281. Burkhart CN, Burkhart CG.  Stool culture to prove blastomycosis.  Journal of the American Academy of Dermatology 2004;50:486-7.
  282. Burkhart CG, Burkhart HR, Black C.  Assessment of polytrap polymers in dermatologic therapy.  Cosmetic Dermatology 2003;16:45-48.
  283. Burkhart CG.  Ivermectin: How much?  Infectious Disease News 2003;16(8):3.
  284. Burkhart CG.  Second vote for Accutane’s low dosing.  Dermatology Times 2003;24(9):8.
  285. Burkhart CG. Renaissance man: Ohio dermatologist fulfilled by his practice, research, writing, raising horses, family ties.  Dermatology Times 2004;25(1):110.
  286. Burkhart CN, Burkhart CG.  Microbiologic principle of biofilms as a major factor in pathogenesis of acne.  International Journal of Dermatology 2003;42:925-927.
  287. Burkhart CG.  One score and ten PDRs ago: The transformation of medical practice.  Journal of Drugs in Dermatology 2004;2:616-617. 
  288. Meinking TL, Burkhart CN, Burkhart CG.  Changing paradigms in dermatology:  common dermatological helminthic infections and cutaneous myiasis.  Clinics in Dermatology 2003;21(5):407-416.
  289. Burkhart, CG.  And the beat goes on: Formulary restriction, generic substitution, prior authorization, drug utilization and now therapeutic interchange.  Journal of Drugs in Dermatology 2004;3:11.
  290. Burkhart CG.  Actinic keratoses: a few comments.  Ohio Dermatological Association’s Dermatology News 2004;2:5-6.
  291. Burkhart CG.  The role of topical immunomodulators in this world of topical steroids.  International Journal of Pediatrics 2004;19:4-6.
  292. Burkhart CG.  New topical combination treatment for vitiligo?  ODA Dermatology News 2004;2:5-6
  293. Burkhart CG.  The endogenous, exogenous, and latent infections with human papillomavirus.  International Journal of Dermatology 2004;43:548-9.
  294. Burkhart CG.  Veni, V.D., Vici: Twelve points about herpes that need to be conquered.  Journal of Drugs in Dermatology 2004;3:127-9.
  295. Burkhart CG.  Isotretinoin use: debate continues. Dermatology Times 2004;25(6):1-3.
  296. Burkhart CG, Burkhart CN.  The saga of insecticide exposure with an increased risk of melanoma.  Journal of Drugs in Dermatology 2004;3:244.
  297. Burkhart CG.  Coffee and heart attacks?  Ohio Dermatological Association’s Dermatology News 2004;2:5-6.
  298. Burkhart CN, Burkhart CG.  Head lice revisited: in vitro standardized tests and differences in malathion formulations.  Archives of Dermatology 2004;140:488-9.
  299. Burkhart CG.  Relationship of treatment-resistant head lice to the safety and efficacy of pediculicides.  Mayo Clinic Proceedings 2004;79:661-6.
  300. Burkhart CN, Burkhart CG.  Pilot study of patients’ satisfaction with nonfluorinated topical steroids compared with a topical immunomodulator in atopiform dermatitis.  International Journal of Dermatology 2004;43:215-9. 
  301. Burkhart CG.  Directions on your prescriptions can eliminate time-eating hassles.  The Patented One-Write Prescription form and method.  Dermatology Times 2004:25(6):84-86. 
  302. Burkhart CG.  Fine-tuning the 1-write treatment form.  Dermatology Times 2004;25(8):12.
  303. Burkhart CG, Burkhart, CN.  5 alpha-reductase and finasteride in pattern alopecia and acne.  Journal of Drugs in Dermatology 2004;3:363-4.
  304. Burkhart CG.  Dermatology Diagnosis:  Spreading, pruritic rash is a family affair: Poison ivy.  Cortlandt Forum 2004;17(9):51-3.
  305. Burkhart CG, Burkhart CN.  Tacrolimus and topical steroids: which is more effective?  British Journal of Dermatology 2004;151:1781-2.
  306. Burkhart CG. Dermatology Diagnosis: Scalp concerns (follicular keloidalis).  Cortlandt Forum  2004;17(10):47-9.
  307. Burkhart CG.  Sterility and purity of liquid nitrogen.  Ohio Dermatological Association’s Dermatology News 2005:3:6-7.
  308. Burkhart CG.  Mystery of liquid nitrogen.   Ohio Dermatological Association’s Dermatology News 2005;3:7.
  309. Burkhart CG.  Check your condoms for carcinogens.  Ohio Dermatological Association’s Dermatology News 2005;3:8.
  310. Burkhart CG.  Light might not be all bad. Ohio Dermatological Association’s  Dermatology News 2005;3:9.
  311. Burkhart CG.  PET scans and isotretinoin.  Ohio Dermatological Association’s Dermatology News 2005;3:10.
  312. Burkhart CG.  A non-textbook, non-invasive diagnostic test for pulmonary deep fungal infections.  Ohio Dermatological Association’s Dermatology News 2005;3:11.
  313. Burkhart CG.  Overcome pediculicide resistance: rating head lice treatment options.  Practical Dermatology 2005;2(1):60-1.
  314. Burkhart CG.  Dermatology Diagnosis: Persistent plaque with severe intermittent pruritus (lichen simplex chronicus).  Cortlandt Forum 2004;17(11):51-2. 
  315. Burkhart CG.  Dermatology Diagnosis: Months-long facial rash with constant burning sensation (perioral dermatitis).  Cortlandt Forum 2005;18(1):34-7.
  316. Burkhart CG.  Acne biofilms, temperature, and microenvironments.  Journal of the American Academy of Dermatology 2005;52:182.
  317. Burkhart, CG.  The ubiquitous presence of warts on human skin needs acknowledgement for better direction of papillovirus research.  British Journal of Dermatology 2005;152:393-4.
  318. Burkhart CG, Burkhart CN.  Oral ivermectin for Phthirus pubis.  Journal of the American Academy of Dermatology 2004;51:1037-8.
  319. Burkhart CG.  A dermatologist’s response to the American Academy of Pediatrics Guidelines on head lice.  Journal of Drugs in Dermatology 2005;4:14-15.
  320. Burkhart CG.  Dermatology Diagnosis:  Inflammation, pain, and pruritus in a woman’s skin fold (intertrigo).  Cortlandt Forum 2005;18(4):42-45.
  321. Burkhart CG, Burkhart CN.  The mole theory: primary function of melanocytes and melanin may be antimicrobial defense and immunomodulation  (not solar protection).  International Journal of Dermatology 2005;44:340-2.
  322. Burkhart CN, Burkhart CG.  Bimodal temporal distribution of herpetic reactivation: apparent subset of patients with therapeutic ramifications.  Mayo Clinic Proceedings 2005;80:287-8.
  323. Burkhart CG.  Dermatology Diagnosis: Petechial rash and high fever in a hiker (Rocky Mountain Spotted Fever).  Cortlandt Forum 2004;18(5):44-7.
  324.  Burkhart CG.  Dysplastic Nevus.  New England Journal of Medicine 2004;350:1258.
  325. Burkhart CG.  The diminishing value of the Physicians’ Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.  Journal of Drugs in Dermatology 2005;4:414-5.
  326. Burkhart CG.  Contact urticaria from Mars chocolate candy bar.   Ohio Dermatological Association’s Dermatology News 2005;3:8.
  327. Burkhart CG.  Dermatology Diagnosis: Exacerbation of asymptomatic flat facial lesions (flat warts).  Cortlandt Forum 2005;18(10):59-60.
  328. Burkhart CG.  Toilet seat contact dermatitis. Ohio Dermatological Association’s  Dermatology News 2005;4:7.
  329. Burkhart CG.  Finally a handout that all your patients can use….not!!!   Ohio Dermatological Association’s Dermatology News 2005;3:9.
  330. Burkhart CG.  Chronic use of azithromycin may be associated with a risk of hearing loss.   Ohio Dermatological Association’s Dermatology News 2005;4:7.
  331. Burkhart CG.  Chronic antibiotic use may increase risk of skin cancer.   Ohio Dermatological Association’s Dermatology News 2005;4:8.
  332. Burkhart CG.  Nature reveals another immunological trick in species competition (the counter Darwinian effect). Ohio Dermatological Association’s  Dermatology News 2005;4:9.
  333. Burkhart CG. Yogi’s left-handed comments were secondary to circulation problems.   Ohio Dermatological Association’s Dermatology News 2005;4:10.
  334. Burkhart CG.  Immune coating of microbes makes pathogens temporarily invisible, allowing skin penetration.  Ohio Dermatological Association’s Dermatology News 2005;4:11.
  335. Burkhart CG.  Chloasma in a man due to oral hormone replacement.  SkinMed: Dermatology for the Clinician 2006;5:46-47.
  336. Burkhart CG. Light’s role in immunomodulation and medical therapy.  Journal of the American Academy of Dermatology 2005;53:1099-1100.
  337. Burkhart CG.  Reassessment of pharmacological action of retinoids in acne therapeutics and the emerging ‘fifth’ factor in acne pathogenesis, namely the Propionibacterium acnes biofilm  Dermatology Times 2005;26(9):8.
  338. Burkhart CG.  Dysplastic nevi, Mondegreens, and a survey: the answer is blowing in the wind.  Journal of Cutaneous Pathology 2005:32:642-3.
  339. Burkhart CG, Burkhart CN.  Penetration enhancers improve therapeutic effectiveness of topical immunomodulators.  Dermatology Online Journal 2005;11(3):39. http://dermatology.cdlib.org
  340. Burkhart CG.  Stabilize the joint associated with myxoid cyst prior to surgical procedure.  Dermatology Online Journal 2005;11(3):9. http://dermatology.cdlib.org
  341. Burkhart CN, Burkhart CG.  Head lice: scientific assessment of the nit sheath with clinical ramifications and therapeutic options.  Journal of the American Academy of Dermatology 2005;53:129-33. 
  342. Burkhart CG.  Reports of immunologic reactions to imiquimod: an assessment of actinic dermatoses and treatment concerns in this era of litigation lotto.  Dermatology Online Journal 2005;11(3):40. http://dermatology.cdlib.org
  343. Burkhart CG.  Focus on herpes acquisition and transmission.  Journal of Drugs in Dermatology 2005;4:378-383.
  344. Burkhart CG. Dermatology Diagnosis: Refractory flaking and itching on a young man’s scalp (seborrheic dermatitis).  Cortlandt Forum 2005;18(11):53-4.
  345. Burkhart CG.  If you see a soldier in the office with an ulcer from Iraq or Afghanistan, consider leishmania.  Ohio Dermatological Association’s Dermatology News 2005;5:6.
  346. Burkhart CG.  A true mystery for you to solve regarding liquid nitrogen.   Ohio Dermatological Association’s Dermatology News 2005;5:9.
  347. Burkhart CG.  Can benzoyl peroxide be made more effective?  Toledo dermatologist says “yes,” by adding stimulant, accelerator, modifying vehicle.  Dermatology Times 2005;25(supplement 4):S25.
  348. Burkhart CG.  Overcome pediculicide resistance: rating head lice treatment options.  Practical Dermatology 2005;2(1):60-61.
  349. Burkhart CG. Dermatology Diagnosis:  Palmar and plantar lesions with malaise and a headache (Syphilis).  Cortlandt Forum 2005;18(12):54-57.
  350. Burkhart CG. Dermatology Diagnosis: Periocular erythema and swelling with muscle weakness (Dermatomyositis).  Cortlandt Forum 2006;19(1):42-45.
  351. Burkhart CG.  Dermatology Diagnosis:  Hyperkeratotic plaques that run in the family (Palmoplantar keratoderma).  Cortlandt Forum 2006;19(2):69-72.
  352. Burkhart CG.  Dermatology Diagnosis: Rapidly enlarging conical lesion on the sole (Cutaneous horn).  Cortlandt Forum 2006;19(3):61-63.
  353. Burkhart CG, Pchalek I.  Over-the-counter cryotherapies not so cold.  Dermatology Times 2005;26(11):40.
  354. Burkhart CG.  Two wart controversies are brewing, one involving vaccination.   Ohio Dermatological Association’s Dermatological News 2006;6:5.
  355. Burkhart CG.  The other wart controversy involves over-the-counter cryotherapies---do they work?   Ohio Dermatological Association’s Dermatological News 2006;6:6.
  356. Burkhart CG.  Mark it down—on  May 17, 2006, JAMA attacked the biologics. Ohio Dermatological Association’s   Dermatological News 2006;6:7.
  357. Burkhart CG.  The Brits want a revised, and more relaxed, public health policy on sun exposure. Ohio Dermatological Association’s  Dermatological News 2006;6:8.
  358. Burkhart CG.  Study finds bias in peer review!!  Can it be true?  Ohio Dermatological Association’s Dermatological News 2006;6:9.
  359. Burkhart CG.  Is the dermatitis under soccer shin guards an allergic or irritant reaction?  Ohio Dermatological Association’s Dermatological News 2006;6:10.
  360. Burkhart CG.  The $100,000 question for those with obstructive sleep apnea: Do you want the CPAP continuous positive air-way pressure machines complete with plastic masks and buzzers?  Or do you want didgeridoo lessons? Ohio Dermatological Association’s  Dermatological News 2006;6:11.
  361. Burkhart CG.  God gave us acne as a method to ward off potential mates until the afflicted individual is some years past the age of reproductive maturity, and thus emotionally, intellectually, and physically fit to be a parent.  Ohio Dermatological Association’s Dermatological News 2006;7:4.
  362. Burkhart CG.  Perfectionism, acne, and appearance concerns (the psychology of acne).  Ohio Dermatological Association’s Dermatological News 2006;7:5.
  363. Burkhart CG.  Ocean vacationers beware of Vibrio bacterial infections.   Ohio Dermatological Association’s Dermatological News 2006;5:7.
  364. Burkhart CN, Burkhart CG.  Assessment of frequency, transmission, and genitourinary complications of enterbiasis (pinworms).  International Journal of Dermatology 2005;44:837-40.
  365. Burkhart CG, Scheinfeld NS.  Benzoyl peroxide skin washes: basis, logic, effectiveness, and tolerance.  SkinMed 2005;4(6):370-96.
  366. Burkhart CG, Burkhart CN.   Safety and efficacy of pediculicides for head lice.  Expert Opinion 2006;5(1):169-79.
  367. Burkhart CG.  Reporting NRL allergen levels with examination gloves.   Ohio Dermatological Association’s Dermatological News 2006;5:7.
  368. Burkhart CG.  What do you take Viagra for? Ohio Dermatological Association’s  Dermatological News 2006;7:8.
  369. Burkhart CG.  Myxoid cysts: a non-surgical treatment that works (or so they say).   Ohio Dermatological Association’s Dermatological News 2006;7:9.
  370. Burkhart CG, Burkhart CN.  Decreased efficacy of topical anesthetic creams in presence of benzoyl peroxide.  Dermatologic Surgery 2005;31:1479-80.
  371. Burkhart CG.  Irritant-induced enhancement of induction and elicitation of sensitization for the treatment of seborrheic keratoses.  International Journal of Dermatology 2006;45:1240-1242.
  372. Burkhart CG.  Do you have the “hanging fat sign?”  Ohio Dermatological Association’s Dermatological News 2006;7:9.
  373. Burkhart CG.  Pododermatitis: Do you know how to treat it? Ohio Dermatological Association’s  Dermatological News 2006;7:7.
  374. Burkhart CG.  Lousy Problem?  Buffalo News 2006;11:6.
  375. Burkhart CG.  The basement membrane problem with lichen planus.  SkinMed 2006;5(4):167-8.
  376. Burkhart CG, Isham N, Burkhart CN. Expanded yeast and bacterial coverage: synergistic activity by free radicals formed by combining an allylamine with benzoyl peroxide.  British Journal of Dermatology 2006;154:341-4.
  377. Burkhart CG.  Dermatology Diagnosis: Erythematous facial rash followed by reticulated eruption (Erythema infectiosum).  Cortlandt Forum 2006;19(5):67-69.
  378. Mumcuoglu KY, Meinking T, Burkhart CN, Burkhart CG.  Head louse infestations: the “no-nit” policy and its consequences.  International Journal of Dermatology 2006;45:891-6. 
  379. Burkhart CN, Burkhart CG.  The Clinical Use of Deoxycholate for Lipomas and Earwax.  Dermatologic Surgery 2006;32:1217.
  380. Burkhart CG, Burkhart CN.  Antibacterial properties of benzoyl peroxide in aerobic and anaerobic conditions.  International Journal of Dermatology 2006;45:1373-4.
  381. Burkhart CG, Burkhart CN.  Ice cream headaches and cryotherapy of actinic keratoses.  International Journal of Dermatology 2006;45:1116-7.
  382. Burkhart CG, Burkhart CN.  Asphyxiation of lice with topical agents, not a reality…yet.  Journal of the American Academy of Dermatology 2006;54:721-2.
  383. Burkhart CG.  The search for topical treatments for seborrheic keratoses continues.  International Journal of Dermatology 2006;45:1110-2.
  384. Burkhart CG, Burkhart AK.  Going over over-vaccinating horses for herpes infections again.  Holistic Medicine 2006:47:33-34.
  385. Burkhart CG.  Dermatology Diagnosis:  Spotty hair loss in a stressed-out young woman (Trichorrhexis nodosum).  Cortlandt Forum 2006;19(7): 72-6.
  386. Burkhart CN, Burkhart CG.  Genome sequence of Propionibacterium acnes reveals immunogenic and surface-associated genes confirming existence of the acne biofilm.  International Journal of Dermatology 2006;45:872.
  387. Burkhart CG.  Alternate therapies for head lice with oral and topical ivermectin.  Dermatology Online Journal (accepted 2006). . http://dermatology.cdlib.org
  388. Burkhart CG.  Red weeping nodule on the hand of a young farmer (Orf).  Cortlandt Forum 2006(9);19:75-79.
  389. Burkhart CG.  Mesalamine may be preferable to sulfasalazine in dermatologic therapeutics.  International Journal of Dermatology 2006;45:779-80.
  390. Burkhart CG. The role of soap in acne.  Dermatology Online Journal 2006;12:4. http://dermatology.cdlib.org.
  391. Burkhart CG, Burkhart CN.  A chemical look at benzoyl peroxide may prove helpful.  Journal of Drugs in Dermatology 2006;5:705-6.
  392. Burkhart CG.  Wart controversies brewing, one involving vaccination.  Ohio Dermatologic Association Dermatologic News 2006:4:9.
  393. Burkhart CG.  Over vaccinating for certain diseases causes problems.   Holistic Horse 2006;12:33.
  394. Burkhart CG.  A guide to recognizing and treating herpes.  Clinical Advisor 2006;35(11):23-26.
  395. Burkhart CG.  Benzoyl peroxide and tumorigenesis—Is there a connection?  Dermatology Times 2006;27(12):12.
  396. Burkhart CG.  Guide to the treatment of herpes.  The Clinical Advisor 2006;9(12):14-17.
  397. Burkhart CG.  A chemical look at benzoyl peroxide may prove helpful.  Journal of Drugs in Dermatology 2006;5:705.
  398. Burkhart CG.  Hot air exterminates the bugs and their eggs?  Health Day: Women’s Health News 2006:11:6. 
  399. Burkhart CN, Burkhart CG.  Bacterial symbiotes, their presence in head lice, and potential treatment avenues.  Journal of Cutaneous Medicine and Surgery 2006;10:2-6.
  400. Burkhart CG, Burkhart CN.  Safety and efficacy of pediculicides for head lice.  U.S. Special Populations: Pediatric Healthcare: Pediculosis 2006;5:62-65.
  401. Burkhart CG.  Top ten head lice concerns.  SkinMed 2006;5:269-70.
  402. Burkhart CG.  Head lice therapies revisited.  Dermatology Online Journal 2006;12(6):3. http://dermatology.cdlib.org
  403. Burkhart CG.  Herpes simplex: Guide to recognition and therapy.  Cortlandt Forum 2006;19(12):46-51.
  404. Burkhart CG.  Herpes infections.  The Clinical Advisor 2007;10(1):13.
  405. Burkhart CG.  Dermatology Diagnosis: Month-long nonpruritic bilateral malar rash in an 18-month-old child (Neonatal acne). Cortlandt Forum 2007(1):57-60. 
  406. Burkhart CG.  Are ultrasounds and lasers totally safe?  Ohio Dermatological Association’s Dermatologic News 2007;8:15.
  407. Burkhart CG.  Message from the president: Ask what the Ohio Dermatological Association can do for you.  Ohio Dermatological Association’s Dermatologic News 2007;8:1.
  408. Burkhart CG.  Ohio Dermatologic Association Strategic Plans for 2006-7 and beyond.  Ohio Dermatological Association’s Dermatologic News 2007;8:5-13.
  409. Burkhart CG.  Localized hair breakage caused by ants.  Ohio Dermatological Association’s Dermatologic News 2007;8:13.
  410. Burkhart CG.  Biologists and some dermatologists continue to suggest need for some sun.  Ohio Dermatological Association’s Dermatologic News 2007;8:15.
  411. Burkhart CG, Burkhart CN.  Treatment of acne vulgaris without antibiotics: tertiary amines/benzoyl peroxide combination versus benzoyl peroxide alone (Proactiv solution).  International Journal of Dermatology 2007;46:89-93.
  412. Burkhart CG.  Pumped-up poison ivy.  Ohio Dermatological Association’s Dermatologic News 2007;1:15.
  413. Burkhart CG.  Dermatology Diagnosis: Erythematous facial rash followed by reticulated eruption (Erythema infectiosum).  The Clinical Advisor 2007;10(1):84-87.
  414. Burkhart CG.  Long-term safety with lasers and intense pulsed light virtually untested.  International Journal of Dermatology 2007;46:210-211.
  415. Burkhart CG.  Dermatological concerns with toilet paper.  Ohio Dermatological Association’s Dermatologic News 2007;8:14.
  416. Burkhart CG.  Sexually-induced fixed drug eruption.  Ohio Dermatological Association’s Dermatologic News 2007;8:15.
  417. Burkhart CG.  Leg crossers’ dimple “appears to be extremely common.”  Ohio Dermatological Association’s Dermatologic News 2007;8:16.
  418. Burkhart CG.  Dermatology Diagnosis:  A black heel lesion proves worrisome to a young basketball player (Telon noir).  Cortlandt Forum 2007;20(2):57-60.
  419. Burkhart CG.  Dermatology Clinic: Red weeping nodule on the hand of a farmer (Orf Disease).  Clinical Advisor 2007;35:11-12.
  420. Burkhart CG, Burkhart CN.  Trichorrehexis nodosa revisited.  SkinMed: Dermatology for the Clinician 2007;6: 57-58.
  421. Burkhart CG.  Fit and healthy:  Acne remedy. 7/25/2007  http://fitandhealthy.com/acne-remedy 
  422. Burkhart CG.  The medicine environment, the pharmaceutical influence, and the business of dermatology.  Ohio Dermatological Association’s Dermatologic News 2007;9:1-3.
  423. Burkhart CG.  The Ohio Dermatological Association and Accutane.  Ohio Dermatological Association’s Dermatologic News 2007;9:13.
  424. Burkhart CG.  Antibiotics for psoriasis.  Ohio Dermatological Association’s Dermatologic News 2007;9:9.
  425. Burkhart CG.  Dermatology Diagnosis:  Pruritic, erythematous swelling in a young woman’s colorful tattoo (Tattoo granuloma).  Cortlandt Forum 2007;20(4):59-65.
  426. Burkhart CG.  Cutaneous lupus.  Clinical Advisor 2007;7(4): 20-22.
  427. Burkhart CG.  Telon noir.  Clinical Advisor 2007;7(6):27-29.
  428. Burkhart CG.  Orf.  Clinical Advisor 2007;7(7):18-20.
  429. Burkhart CG.  Eruptive xanthomas.  Clinical Advisor 2007;7(9):17-20.
  430. Burkhart CG.  Tattoo granuloma.  Clinical Advisor 2007;7(10):24-27. 
  431. Burkhart CG.  Recent immunologic considerations regarding the itch and treatment of scabies.  Dermatology Online Journal 2006;12(7):7. 
  432. Burkhart CG.  Wrestlers’ sweat found to contain Hepatitis B.  Ohio Dermatological Association’s Dermatologic News 2007;9:10.
  433. Burkhart CG.  Tuberculosis is back in the states after clearing customs in Champlain, New York.  Ohio Dermatological Association’s Dermatologic News 2007;9:11.
  434. Burkhart CG.  Cosmetic surgery comes in jars now.  Ohio Dermatological Association’s Dermatologic News 2007;9:10.
  435. Burkhart CG.  Options still limited for age-old problem: Lice resistant to many traditional treatments.  Dermatology Times 2007;28(6):40-41.
  436. Burkhart CG.  Look for the tell-tale signs of asymptomatic hyperpigmentation and lichenification of skin over the forearms bilaterally.  Ohio Dermatological Association’s Dermatologic News 2007;9:11.
  437. Burkhart CG.  Two perils of hospital washing.  Ohio Dermatological Association’s Dermatologic News 2007;9:10.
  438. Burkhart CG.  Follow-up on laser safety and risk of melanoma.  Ohio Dermatological Association’s Dermatologic News 2007;9:11.
  439. Burkhart CG.  This might increase your dander:  allergy to cow’s hair reported in Croatia.  Ohio Dermatological Association’s Dermatologic News 2007;9:12.
  440. Burkhart CG.  Dermatology Diagnosis:  Worsening pigmentation on the legs of a young female athlete (Minocycline hyperpigmentation).  Cortlandt Forum 2007;20(7):47-53.
  441. Burkhart CG, Burkhart CN.  Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs.  benzoyl peroxide alone (Proactiv Solution).  International Journal of Dermatology 2007;46:89-93.
  442. Burkhart CG.  Dermatology Diagnosis:  Interphalangeal wart-like lesions that express clear fluid (Myxoid cyst).  Cortlandt Forum 2007;20(8):47-50.
  443. Burkhart CG.  ‘Dysplastic’ debate: term continues to confuse.  Dermatology Times 2007;28(7):6. 
  444. Burkhart CG.  Dermatology Diagnosis:  Genital warts in a neonate as a possible sign on abuse.  Cortlandt Forum 2007;20(9):49-52.
  445. Burkhart CG.  Dermatology Diagnosis:  Deep purple blotches in an elderly man with atrial fibrillation (Senile Purpura).  Cortlandt Forum 2007;20(10):45-46.
  446.   Burkhart CG.  Dermatology Diagnosis:  Recalcitrant red, swollen, pruritic lower-extremity eruption (Stasis dermatitis).  Cortlandt Forum 2007;20(11):39-40.
  447. Burkhart CG.  Dysplastic debate continues: Terms continue to confuse.  Dermatology Times 2007;28(10):6-12.
  448. Burkhart CN, Burkhart CG.  Fomite transmission in head lice.  Journal of the American Academy of Dermatology 2007;56:1044-7.
  449. Burkhart CG.  Dermatology Diagnosis:  Inflamed, sore lesions at the corner of the mouth of an elderly man (Perleche).  Cortlandt Forum 2007;20(12):40-47.
  450. Burkhart CG.  Intermingled areas of varying pigmentation in a young boy (Piebaldism). Cortlandt Forum 2008;21(1):45-47. 
  451. Burkhart CG.  Dermatology Diagnosis:  Recurrent, ulcerating, perforating lesion on the nose (Rodent ulcer).  Cortlandt Forum 2007;21(2):47-50.
  452. Burkhart CG. Scabies, the disease that mite need your attention. Ohio Dermatological Association Dermatologic News 2008;3:4.
  453. Burkhart CG.  Tattoo technology allows for modern impermanence: that is, disappearing ink.  Ohio Dermatological Association’s Dermatologic News 2008;3:9.
  454. Burkhart CG.  The Propionibacterium acnes biofilm story: are you a believer… yet? Ohio Dermatological Association’s Dermatologic News 2008;3:10.
  455. Burkhart CG.  Minocycline not only has benefit for acne therapeutics, but it also improves recovery in strokes. Ohio Dermatological Association’s Dermatologic News 2008;3:11.
  456. Burkhart CG.  Mast cells may not be all bad…they have an anti-inflammatory side. Ohio Dermatological Association’s Dermatologic News 2008;3:12.
  457. Burkhart CG.  Besides methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium, the next new virulent, drug resistant bug is…Acinetobacter baumannii.  Ohio Dermatological Association’s Dermatologic News 2008;3:13.
  458. Burkhart CG.  A look into the future: an ultraviolet blocker that acts by stimulating production of skin melanin.  Ohio Dermatological Association’s Dermatologic News 2008;3:14.
  459. Burkhart CG.  Fifth Disease.  Clinical Advisor 2007;7(4):7-9.
  460. Burkhart CG.  Myxoid cyst.  Clinical Advisor 2008;8(2):19-21.
  461. Burkhart CG.  Genital warts.  Clinical Advisor 2008;8(5):15-17.
  462. Burkhart CG.  Mastocytoma.  Clinical Advisor 2008;8(7):9-12.
  463. Burkhart CG.  Tinea pedis.  Clinical Advisor 2008;8(7):8-10.
  464. Burkhart CG.  Basal cell carcinoma.  Clinical Advisor 2008;8(11):23-25.
  465. Burkhart CG.  Senile purpura.  Clinical Advisor 2008;8(11):21-23.
  466. Burkhart CG.  Cutaneous horn.  Clinical Advisor 2008;8(12):22-24
  467. Burkhart CG.  Finger pulp dermatitis can have a palpable cause.  Ohio Dermatological Association’s Dermatologic News 2008;3:15.
  468. Burkhart CG.  Maggot therapy on ulcers work via the anti-bacterial properties in their stools, not by their eating habits.  Ohio Dermatological Association’s Dermatologic News 2008;3:16.
  469. Burkhart CG.  Forget embryos, skin can be the source of stem cells.  Ohio Dermatological Association’s Dermatologic News 2008;3:17.
  470. Burkhart CG.  Helpful hints:  Scabies, the disease that mite need your attention.  Ohio Dermatological Association’s Dermatologic News 2008;3:4.
  471. Burkhart CG.  Dermatology Diagnosis:  Vesicles and inflammation on a teenager wrestler’s feet (Tinea pedis).  Cortlandt Forum 2007;21(3):45-48.
  472. Burkhart CG, Burkhart CN.  Expanding the microcomedone theory and acne therapeutics:  Propionibacterium acnes biofilm produces glue that holds corneocytes together to form plug.  Journal of the American Academy of Dermatology 2007;57:722-4. 
  473. Burkhart CG, Pchalek I, Adler M, Burkhart CN.  An in vitro study comparing temperatures of over-the-counter wart preparations versus liquid nitrogen.  Journal of the American Academy of Dermatology 2007;57:1019-20.
  474. Burkhart CG.  Methicillin-resistant Staphylococcus aureus is a superbug: caution advised.  Skin and Allergy News 2008;39(4):16. 
  475. Burkhart CG, Burkhart CN.  More on methicillin-resistant Staphylococcus aureus
  476. Skin and Aging 2008;16(3):11.
  477. Burkhart CN, Burkhart CG.  Head lice, symbiotic bacteria, the Journal of Cutaneous Medicine and Surgery, and taxonomic precedence.  Journal of Cutaneous Medicine and Surgery 2008;12:49. 
  478. Burkhart CG, Burkhart CN.  Antibacterial properties of soluble benzoyl peroxide.
  479. International Journal of Dermatology 2008;47:301-2.
  480. Burkhart CG.  Dermatology Diagnosis:  A single non-pruritic growing erythematous plaque (Erythema annulare centrifugum).  Cortlandt Forum 2008;22(5):37-40.
  481. Burkhart CG, Burkhart CN.  Clarification:  510k is a premarket notification; it provides no patent or FDA approval.  Journal of Drugs in Dermatology 2008;7:105.
  482. Burkhart CG.  Tattoo pigment can mimic melanoma spread to lymph nodes.  Ohio Dermatological Association’s Dermatologic News 2008;4:6.
  483. Burkhart CG.  A second episode of Lyme disease:  recurrence or a second tick bite?  Ohio Dermatological Association’s Dermatologic News 2008;4:7.
  484. Burkhart CG.  MRSA contamination controlled with aerosolized hydrogen peroxide.  Ohio Dermatological Association’s Dermatologic News 2008;4:8.
  485. Burkhart CG.  Photo instability of sunscreens now being reported.  Ohio Dermatological Association’s Dermatologic News 2008;4:9.
  486. Burkhart CG.  The value of Zostavax.  Ohio Dermatological Association’s Dermatologic News 2008;4:10.
  487. Burkhart CG.  The importance of fat in neuroendocrine, immunomodulatory, and central nervous effects.  Ohio Dermatological Association’s Dermatologic News 2008;4:11.
  488. Burkhart CG.  The best treatment for urticaria.  Ohio Dermatological Association’s Dermatologic News 2008;4:12.
  489. Burkhart CG.  Pruritic scalp:  a new clinical entity?  Ohio Dermatological Association’s Dermatologic News 2008;4:13.
  490. Burkhart CG.  Recurrent deep ulceration exposes the nasal septum (Basal cell carcinoma).  The Clinical Advisor 2008;8(11):12-15. 
  491. Burkhart CG.  Rapidly enlarging conical lesion on the plantar surface.  The Clinical Advisor 2009;8(12):1-4. 
  492. Burkhart CG.  Therapeutic implications of chemically- and biologically-altered sebum being one cause of seborrheic dermatitis.  Ohio Dermatological Association’s Dermatologic News 2008;4:14.
  493. Burkhart CG.  Botox can spread along nerve cells and remain active beyond the injection site….in rats.  Ohio Dermatological Association’s Dermatologic News 2008;4:15.
  494. Burkhart CG.  Dermatology alert:  possible side effects from dermatoscope reported.  Ohio Dermatological Association’s Dermatologic News 2008;4:16.
  495. Burkhart CG, Burkhart CN.  Use of a keratolytic agent with occlusion for topical treatment of hyperkeratotic seborrheic keratoses.  SkinMed 2008;7(1):15-18.
  496. Burkhart CG.  Dermatology Diagnosis:  Thick, dark brown, warty lesion on elderly woman’s cheek (Seborrheic keratosis).  Cortlandt Forum 2008;21(5):41-43.
  497. Burkhart CG, Burkhart CN.  Therapeutic implications of chemically-and biologically-altered sebum being one cause of seborrheic dermatitis.  The Open Dermatology Journal 2008;2:1-4.
  498. Burkhart CG, Burkhart CN.  Is there risk when prescribing isotretinoin to pilots: might the use of isotretinoin rule out a career in flying?  The Open Dermatology Journal 2008;2:35.
  499. Burkhart CG, Burkhart CN.  Case of sexually-induced, episodic urticaria.  Australian Journal of Dermatology 2008;49:114-115.
  500. Burkhart CG, Burkhart CN.  Assessing treatment of pruritic scalp.  The Open Dermatology Journal 2008;2:32-34.
  501. Burkhart CG.  A patient-oriented approach to acne, rosacea, perioral dermatitis, and isotretinoin with working patient informational/instructional sheets and a review of pathophysiology and mechanisms of therapeutic agents.  The Open Dermatology Journal 2008;2:36-43.
  502. Burkhart CG.  Patient-oriented treatment for urticaria: a three-step approach with information/instructional sheets.  The Open Dermatology Journal 2008;2:57-63.
  503. Burkhart CG, Burkhart CN.  Hairy concerns:  use of instructional/informational sheets for assistance with disorders of hair.  The Open Dermatology Journal 2008;2:77-82.
  504. Burkhart CG, Burkhart CN.  Similar to acne vulgaris, bacteria may produce biological glue that causes plugging of the meibomian gland leading to chalazions.  Clinical and Experimental Ophthalmology 2008;36:295.
  505. Burkhart CG, Burkhart CN.  Usable options in the treatment of delusions of parasitosis.  Journal of the European Academy of Dermatology and Venereology 2008;22:1026-1027.
  506. Burkhart CG.  The new doctor-physician paradigm.  Ohio Dermatological Association’s Dermatologic News 2009;4:1.
  507. Burkhart CG.  The Food and Drug Administration and herbal treatments. Ohio Dermatological Association’s Dermatologic News 2009;4:2.
  508. Burkhart CG.  Nickel and public health.  Ohio Dermatological Association’s Dermatologic News 2009;4:3.
  509. Burkhart CG.  Buruli ulcers: the cause has been delineated.  Ohio Dermatological Association’s Dermatologic News 2009;4:4.
  510. Burkhart CG.  My last sequel on liquid nitrogen.  Ohio Dermatological Association’s Dermatologic News 2009;4:5.
  511. Burkhart CG.  Human papillomavirus and skin tags: is there an association.  Ohio Dermatological Association’s Dermatologic News 2009;4:6.
  512. Burkhart CG.  A better stain for documentation of superficial fungal infections.  Ohio Dermatological Association’s Dermatologic News 2009;4:7.
  513. Burkhart CG.  CDC opts to do epidemiological study on Morgellons disease.  Ohio Dermatological Association’s Dermatologic News 2009;4:8.
  514. Burkhart CG.  Contact dermatitis from suture materials.  Ohio Dermatological Association’s Dermatologic News 2009;4:9.
  515. Burkhart CG.  New terbinafine oral granules and their place in clinical care.  Ohio Dermatological Association’s Dermatologic News 2009;4:10.
  516. Burkhart CG.  The cause of granuloma annulare might be Borrelia microorganisms.  Ohio Dermatological Association’s Dermatologic News 2009;4:11.
  517. Burkhart CG.  Vaccination against acne closer to reality?  Ohio Dermatological Association’s Dermatologic News 2009;4:12.
  518. Burkhart CG.  Popsicle panniculitis: Is it contagious? Is there a cure? Ohio Dermatological Association’s Dermatologic News 2009;4:13.
  519. Burkhart CG.  Pruritic (or sensitive) scalp…does such a condition exist?  Ohio Dermatological Association’s Dermatologic News 2009;4:14.
  520. Burkhart CG.  Watch where you sit…there are allergens in furniture.  Ohio Dermatological Association’s Dermatologic News 2009;4:15.
  521. Burkhart CG.  Tort law in Japan.  Ohio Dermatological Association’s Dermatologic News 2009;4:16.
  522. Burkhart CG, Burkhart CN.  Usable options in the treatment of delusions of parasitosis.  Journal of the European Academy of Dermatology and Venereology  2008;22:1026.
  523. Burkhart CG, Burkhart CN.  The chemistry and synergy of benzoyl peroxide with clindamycin.  British Journal of Dermatology 2008;159:480-481.
  524. Burkhart CG.  Another threat to the availability of isotretinoin:  ocular side effects have aviation authorities considering restricting use from (even potential) pilots.  Dermatology Online Journal 2008;14:7-10. 
  525. Burkhart CG.  Dermatology Diagnosis:  Tender, rupturing facial pustule in an otherwise healthy man (Cutaneous dental sinus tract).  Cortlandt Forum 2008;22(9):37-39.
  526. Burkhart CG.  Tylosis.  Clinical Advisor 2009;9(1):15-17. 
  527. Burkhart CG, Burkhart CN.  Can cryosurgery in dermatology be augmented or assisted by pretreatment of skin?  International Journal of Dermatology 2008;47:1082-1083. 
  528. Burkhart CG, Burkhart CN.  Clinical assessment by atopic dermatitis patients of response to reduced soap bathing: a pilot study.  International Journal of Dermatology 2008;47:1216-1217.
  529. Burkhart CG, Burkhart CN.  Aluminum alters sweating by constricting the dermal duct lumen.  International Journal of Dermatology 2008;47:1306-1307.
  530. Burkhart CG, Burkhart CN.  Use of informational/instructional sheets with eczema patients.  The Open Dermatology Journal 2008;2: 98-104.
  531. Burkhart CG, Burkhart CN.  Melanoma risk factors include insecticides and occupational exposures.  International Journal of Dermatology 2009;48:210.
  532. Burkhart CG.  Terbinafine therapeutic tips.  Practical Dermatology 2009;6(1):9. 
  533. Burkhart CG, Burkhart CN.  Qualitative, not quantitative, alterations of sebum important in seborrheic dermatitis.  Journal of the European Academy of Dermatology and Venereology 2009;23:441.
  534. Burkhart CG, Addapa V, Burkhart CN.  Use of bile salts namely cholate and deoxycholate for earwax removal.  The Open Dermatology Journal 2009;3:1-3.
  535. Burkhart CG, Burkhart CN.  Pityriasis alba: a condition with possibly multiple etiologies.  The Open Dermatology Journal 2009;3:7-8.
  536. Burkhart CG, Burkhart CN.  Recommendation for a simple, office-friendly, standardized testing for head lice. The Open Dermatology Journal 2009;3:9-10.
  537. Burkhart CG, Black C, Burkhart CN.  A topical application containing sucralfate, zinc oxide and ketoconazole provides high patient satisfaction in the treatment of intertrigo.  The Open Dermatology Journal 2009;3:11-13.
  538. Burkhart CG.  Dermatology Look alike:  Dysplastic Nevi.  Cortlandt Forum 2009;23(1):37-39.
  539. Burkhart CG, Burkhart CN.  Serological testing for herpes can lead to misinterpretation in disease transmission.  The Open Dermatology Journal 2009;3:14-15. 
  540. Burkhart CG.  The atopic lament:  to bath or not to bath.  Ohio Dermatological Association’s Dermatologic News 2009;5:11.
  541. Burkhart CG.  Numbing creams helpful for uremic pruritus.  Ohio Dermatological Association’s Dermatologic News 2009;5:12.
  542. Burkhart CG.  Is golf bad for hearing?  Ohio Dermatological Association’s Dermatologic News 2009;5:13.
  543. Burkhart CG.  What should the thermostat on hot water heaters read?  Ohio Dermatological Association’s Dermatologic News 2009;5:14.
  544. Burkhart CG.  Another source of condom allergy disclosed.  Ohio Dermatological Association’s Dermatologic News 2009;5:15.
  545. Burkhart CG.  Oral isotretinoin:  benefits for depression and cutaneous aging as well as dosing considerations.  Ohio Dermatological Association’s Dermatologic News 2009;5:16.
  546. Burkhart CG.  Head lice in the news…again.  Ohio Dermatological Association’s Dermatologic News 2009;5:17.
  547. Burkhart CG.  Elderly woman’s thick warty lesion (Seborrheic keratosis).  The Clinical Advisor 2009;9(5):1-4. 
  548. Burkhart CG.  Distinguishing dysplastic nevi.  The Clinical Advisor 2009;9(3):11-14. 
  549. Burkhart CG.  Exacerbation of asymptomatic flat facial lesions (flat warts).  The Clinical Advisor 2009;9(7):20-22. 
  550. Burkhart CG.  Skin fusion on the fingers and toes of an adolescent girl (Dystrophic epidermolysis bullosa).  The Clinical Advisor 2009;9(7):1-4. 
  551. Burkhart CG. Pigmentation of the legs of a young female athlete.  The Clinical Advisor 2009;9(4):16-18. 
  552. Burkhart CG.  Months-long facial rash with constant burning sensation.  The Clinical Advisor 9(8): 16-18.
  553. Burkhart CG.  Discrete yellow lesions of the eyelid.  The Clinical Advisor 2009;9(5):23-24.. 
  554. Burkhart CG.  Tender, rupturing pustule of the chin.  The Clinical Advisor 2009;9(7):10-11. 
  555. Burkhart CG.  Target lesions in a patient with acne.  The Clinical Advisor 2009;9(11):22-24. 
  556. Burkhart CG.  Dairy products and acne and cancer.  Ohio Dermatological Association’s Dermatologic News 2009;5:18.
  557. Burkhart CG, Burkhart CN.  Microbiology’s principle of biofilms explains isotretinoin success and allows insight as to possible therapies to prevent relapse.  Journal of Drugs in Dermatology 2009;8;112.
  558. Burkhart CG, Burkhart CN.  Comment on: Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.  J Drugs Dermatol 2009;8:112.
  559. Burkhart CG, Burkhart CN.  Dihydroxyacetone and methods to improve its performance as artificial tanner.  The Open Dermatology Journal 2009;3:42-3
  560. Burkhart CG, Burkhart CN.  If papillomavirus found universally in epidermal tissues, what does that mean if a PCR Pap test is positive?  The Open Dermatology Journal 2009;3:52-53.
  561. Burkhart CG.  Is there a place for ethics and morals in dermatology?  Ohio Dermatological Association’s Dermatologic News 2010;6:8.
  562. Burkhart CG.  American Academy of Dermatology has an ethics committee to assure members’ adherence to the code of medical ethics.  Ohio Dermatological Association’s Dermatologic News 2010;6:9.
  563. Burkhart CG.  Shopping for psoriasis medications on the internet.  Ohio Dermatological Association’s Dermatologic News 2010;6:10.
  564. Burkhart CG.  Use of glucocorticosteroids for herpes zoster in elderly questioned. Ohio Dermatological Association’s Dermatologic News 2010;6:11.
  565. Burkhart CG.  Use of sulfasalazine and pentoxifylline for pemphigus.  Ohio Dermatological Association’s Dermatologic News 2010;6:12.
  566. Burkhart CG.  Melanoma epidemic: a midsummer night’s dream?  Ohio Dermatological Association’s Dermatologic News 2010;6:13.
  567. Burkhart CG, Burkhart CN.  Overview of sulfonamides and related medications: query if mesalamine should be preferred over dapsone and sulfasalazine.  The Open Dermatology Journal 2009;3:65-67.
  568. Burkhart CG.  Skin fusion on the fingers and toes of an adolescent girl (Dystrophic epidermolysis bullosa).  The Clinical Advisor 2009;9(7):1-4. 
  569. Burkhart CG, Burkhart CN.  ‘Heparin allergy’ secondary to preservative, namely benzyl alcohol.  The Open Dermatology Journal 2009;3:63-64.
  570. Burkhart CG.  Increasing scalp rash blamed on a haircut (Acne keloidalis).  Clinical Advisor 2009;12(6):24-5.
  571. Burkhart CG.  Persistent plaque with severe intermittent pruritus (lichen simplex chronicus).  Clinical Advisor 2009;12(12):14-5.
  572. Burkhart CG.  Area of varying pigmentation in a young boy (Piebaldism).  Clinical Advisor 2009;12(8):16-7.
  573. Burkhart CG.  Pressure-induced bumps and erythema (Pressure urticaria).  Clinical Advisor 2010;13(2):18-9.
  574. Burkhart CG.  ‘Lone’ atrial fibrillation precipitated by monosodium glutamate and aspartame.  International Journal of Cardiology 2009;141:307-308.
  575. Burkhart CG.  Empathy neurons.  Ohio Dermatological Association’s Dermatologic News 2010;4:8.
  576. Burkhart CG.  FDA rules on benzoyl peroxide: soon no more prescription benzoyl peroxide washes.  Ohio Dermatological Association’s Dermatologic News 2010;4:9.
  577. Burkhart CG.  What is the correct dosing of isotretinoin.  Ohio Dermatological Association’s Dermatologic News 2010;4:10.
  578. Burkhart CG.  Minocycline has redeeming qualities.  Ohio Dermatological Association’s Dermatologic News 2010;4:11.
  579. Burkhart CG.  Insects: the original white meat.  Ohio Dermatological Association’s Dermatologic News 2010;4:12.
  580. Burkhart CG.  Herpes and Acoustic Neuromas:  Is there a cause and effect to observe?  Medical Hypotheses 2010;74:1013-1014.
  581. Nguyen N, Burkhart CG, Burkhart CN.  Identifying potential pitfalls in conventional herpes simplex virus management.  International Journal of Dermatology 2010;49:987-993.
  582. Burkhart CG.  White areas on the face of a teenager (Pityriasis alba).  The Clinical Advisor 2010;13(1):51-3. 
  583.  Burkhart CG.  Measles.  The Clinical Advisor 2010:31:5-6
  584. Burkhart CG.  Effect of Botox includes hampering of emotional sensitivity.  Ohio Dermatological Association’s Dermatologic News 2010;5:1.
  585. Burkhart CG.  Ciprofloxacin has anti-fibrotic effect with benefit in scleroderma.  Ohio Dermatological Association’s Dermatologic News 2010;5:2.
  586. Burkhart CG.  Low-cost detector for bed bugs developed.  Ohio Dermatological Association’s Dermatologic News 2010;5:3.
  587. Burkhart CG.  Application of terror management theory in dermatology.  Ohio Dermatological Association’s Dermatologic News 2010;5:4.
  588. Burkhart CG.  How are you treating delusions of parasitosis?  Ohio Dermatological Association’s Dermatologic News 2010;5:5.
  589. Burkhart CG.  Pramoxine-based anti-itch lotion for uremic pruritus.  Ohio Dermatological Association’s Dermatologic News 2010;5:6.
  590. Burkhart CG.  Literature dispute: Is masturbation a form of physical urticaria or delayed pressure urticaria?  Ohio Dermatological Association’s Dermatologic News 2010;5:7.
  591. Burkhart CG.  New experimental drug fights hepatitis C (and possibly other immune disorders).  Ohio Dermatological Association’s Dermatologic News 2010;5:8.
  592. Mahendiran M, Burkhart CN, Burkhart CG.  Hyperhidrosis: A review of a medical condition.  The Open Dermatology Journal 2009;3:195-197.
  593. Burkhart CG.  Atrial fibrillation.  Ohio Dermatological Association’s Dermatologic News 2011;6:1.
  594. Burkhart CG.  Injections of melanotropin peptides for photoprotection, photosensitivity, and prevention of nonmelanoma skin cancer.  Ohio Dermatological Association’s Dermatologic News 2011;6:2.
  595. Burkhart CG.  Scabies diagnostics.  Ohio Dermatological Association’s Dermatologic News 2011;6:3.
  596. Burkhart CG.  Future blood-clotting material for sealing wounds quickly.  Ohio Dermatological Association’s Dermatologic News 2011;6:4.
  597. Burkhart CG.  Future treatment of melanoma looks extremely promising by treating the genetics of the tumor.  Ohio Dermatological Association’s Dermatologic News 2011;6:5.
  598. Burkhart CG.  Government accused of allowing the food and drink industry to dictate public policy.  Ohio Dermatological Association’s Dermatologic News 2011;6:6.
  599. Burkhart CG.  Acyclovir for pityriasis rosea.  Ohio Dermatological Association’s Dermatologic News 2011;6:7.
  600. Burkhart CG.  New blood thinner on American market.  Ohio Dermatological Association’s Dermatologic News 2011;6:8.
  601. Burkhart CG.  News for those savoring hairstyles such as pageboy, bouffant, and beehive.  Ohio Dermatological Association’s Dermatologic News 2011;7:1.
  602. Burkhart CG.  Recurrence rates of basal cell carcinoma following Mohs micrographic surgery is….2.5%.  Ohio Dermatological Association’s Dermatologic News 2011;7:2.
  603. Burkhart CG.  Dermatologist is vehemently anti-“Seinfeld.”  Ohio Dermatological Association’s Dermatologic News 2011;7:3.
  604. Burkhart CG.  The Journal of Sexual Medicine lays a bomb on Propecia.  Ohio Dermatological Association’s Dermatologic News 2011;7:4.
  605. Burkhart CG.  New treatment of urticaria.  Ohio Dermatological Association’s Dermatologic News 2011;7:5.
  606. Burkhart CG.  Herpes is not entirely a bad virus.  Ohio Dermatological Association’s Dermatologic News 2011;7:6.
  607. Burkhart CG.  A dissertation on senile purpura.  Ohio Dermatological Association’s Dermatologic News 2011;7:7.
  608. Mahendiran M, Burkhart CG, Burkhart CN.  Herpes: Issues under the cold sore.  The Open Dermatology Journal 2010;4:101-104. 
  609. Nguyen N, Burkhart CN, Burkhart CG.  Review: Identifying potential pitfalls in conventional herpes simplex virus management.  Int J Dermatol 2010;49:987-93.
  610. Burkhart CG.  Question concerning prescription finasteride.  Ohio Dermatological Association’s Dermatologic News 2011;12:15.
  611. Burkhart CG.  Co-pay coupons luring consumers from generics to more expensive brands…Deal?  Or No Deal?  Ohio Dermatological Association’s Dermatologic News 2011;12:16.
  612. Burkhart CG.  Publication suggests pharma undermine top journals and skew medical research.  Ohio Dermatological Association’s Dermatologic News 2011;12:17.
  613. Burkhart CG.  Just so(le) you know.  Ohio Dermatological Association’s Dermatologic News 2011;12:18.
  614. Burkhart CG.  Over-the-counter wart freezing therapies vs liquid nitrogen in clinical practice…who wins????  Ohio Dermatological Association’s Dermatologic News 2011;12:19.
  615. Burkhart CG.  Sodium lauryl sulphate again found to be irritating…so why are some people putting it in creams?  Ohio Dermatological Association’s Dermatologic News 2011;12:20.
  616. Burkhart CG.  Get your bacterial cultures ready as Panton-Valentine leucocidin (PVL) positive Staphylococcus aureus infections can be missed.  Ohio Dermatological Association’s Dermatologic News 2011;12:21.
  617. Burkhart CG.  New treatments for palmoplantar pustulosis…maybe.  Ohio Dermatological Association’s Dermatologic News 2011;12:22.
  618. Burkhart CG.  Science advance in technological skills now include …stretchable electronic adhesive circuitry that can stick to the skin and monitor biological functions.  Ohio Dermatological Association’s Dermatologic News 2011;12:23.
  619. Burkhart CG, Burkhart CN, Black CD.  Use of frozen poloxamer as a base for itchy skin conditions, including irritant contact dermatitis.  International Journal of Dermatology 2011;50:1027-8. 
  620. Crites Melissa, Burkhart CG.  Pityriasis rosea in pregnancy: a cause for concern?  Ohio Dermatological Association’s Dermatologic News 2012;13:17.
  621. Burkhart CG.  Mobile, tablet apps and the like.  Ohio Dermatological Association’s Dermatologic News 2012;13:18.
  622. Burkhart CG.  Compliance with pregnancy prevention programs (PPP) with isotretinoin.  Ohio Dermatological Association’s Dermatologic News 2012;13:19.
  623. Burkhart CG.  The many faces of nickel allergy.  Ohio Dermatological Association’s Dermatologic News 2012;13:20.
  624. Burkhart CG.  Epidemiology study on over 50,000 people regarding seborrheic keratoses.  Ohio Dermatological Association’s Dermatologic News 2012;13:21.
  625. Burkhart CG.  What oral agent do you use for tinea capitis?  Ohio Dermatological Association’s Dermatologic News 2012;13:22.
  626. Burkhart CG.  Where does all the money go that is accumulated from board exams and annual dues by the American Board of Dermatology?  Ohio Dermatological Association’s Dermatologic News 2012;13:23.
  627. Burkhart CG.  A spitting image of health and how saliva can help diagnose disease.  Ohio Dermatological Association’s Dermatologic News 2012;13:24.
  628. Burkhart CG.  Pollutants may affect effectiveness of vaccinations in children.  Ohio Dermatological Association’s Dermatologic News 2012;13:25.
  629. Burkhart CG.  The best treatment for warts is…Ohio Dermatological Association’s Dermatologic News 2012;13:26.
  630. Burkhart CG.  2013 Farmers’ Almanac offers natural treatments for acne.  Ohio Dermatological Association’s Dermatologic News 2013;14:11.
  631. Burkhart CG.  The journal, The Economist, describes a better way to diagnose skin cancers.  Ohio Dermatological Association’s Dermatologic News 2013;14:12.
  632. Burkhart CG.  Sklice for head lice.  Ohio Dermatological Association’s Dermatologic News 2013;14:13.
  633. Burkhart CG.  From the litigation corner comes dual agency in terms of medical residents.  Ohio Dermatological Association’s Dermatologic News 2013;14:14.
  634. Burkhart CG. Tattoos getting bad ink, literally.  Ohio Dermatological Association’s Dermatologic News 2013;14:15.
  635. Burkhart CG.  Nicotinamide for skin cancer prevention!  Ohio Dermatological Association’s Dermatologic News 2013;14:16.
  636. Burkhart CG.  Oral lichen planus and spearmint allergy.  Ohio Dermatological Association’s Dermatologic News 2013;14:17.
  637. Burkhart CG.  Birds catching malaria in Alaska!  Ohio Dermatological Association’s Dermatologic News 2013;14:18.
  638. Burkhart CG.  Myelin sheaths feed neurons metabolites.  Ohio Dermatological Association’s Dermatologic News 2013;14:19.
  639. Burkhart CG.  Finasteride (Propecia) update.  Ohio Dermatological Association’s Dermatologic News 2013;14:20.
  640. Adler M, Pchalek I, Burkhart CG.  Questions about liquid nitrogen delivery charge in state.  Ohio Dermatological Association’s Dermatologic News 2013;14:21.
  641. Burkhart CG.  The initiation of paroxysmal (intermittent) atrial fibrillation with REM sleep due to MSG and free glutamates.  International Journal of Cardiology 2012 Dec 5 PMID 23219130 
  642. Koenig K, Burkhart CG.  Azithromycin and reported increase risk of cardiovascular death.  The Open Dermatology Journal 2012;6:55-56. 
  643. Burkhart CG, Mostow E.  Varicella death in Ohio receiving national attention, highlighting need for childhood vaccination.  Ohio Dermatological Association’s Dermatologic News 2013;15:5.
  644. Burkhart CG.  State Bill 491 allowing nurse practitioner independent practice passed out of the Senate Appropriations Committee by 4-3 vote……in California.  Ohio Dermatological Association’s Dermatologic News 2013;15:6.
  645. Burkhart CG.  Airborne contact dermatitis (ABCD):  Do we appreciate this entity in America? Ohio Dermatological Association’s Dermatologic News 2013;15:7.
  646. Burkhart CG.  Sensitive Skin Syndrome:  another entity appreciated elsewhere, but not in our textbooks.  Ohio Dermatological Association’s Dermatologic News 2013;15:8.
  647. Burkhart CG.  Bed bug blurbs.  Ohio Dermatological Association’s Dermatologic News 2013;15:9.
  648. Burkhart CG.  Wrinkling of hands and feet after soaking help humans handle wet objects more effectively. Ohio Dermatological Association’s Dermatologic News 2013;15:10.
  649. Burkhart CG.  Dermatologic anthropology. Ohio Dermatological Association’s Dermatologic News 2013;15:11.
  650. Burkhart CG.  Respective analysis of mortality in former Olympic athletes. Ohio Dermatological Association’s Dermatologic News 2013;15:12.
  651. Burkhart CG.  Dr. Google syndrome.  Ohio Dermatological Association’s Dermatologic News 2013;15:13.
  652. Burkhart CG.  To tie or not to tie.  Ohio Dermatological Association’s Dermatologic News 2013;15:14.
  653. Burkhart CG.  Fungal decontamination of shoe insoles in clinical practice.  Ohio Dermatological Association’s Dermatologic News 2013;15:15.
  654. Burkhart CG.  Antibiotics for chronic urticarial?  Maybe a reason exists for antimicrobials.  Ohio Dermatological Association’s Dermatologic News 2013;15:16.
  655. Burkhart CG.  Another treatment option for chronic urticarial:  low pseudo allergen diet.  Ohio Dermatological Association’s Dermatologic News 2013;15:17.
  656. Burkhart CG.  KOH for warts.  Ohio Dermatological Association’s Dermatologic News 2013;15:18.
  657. Burkhart CG.  Botulinum toxin A (BTA) for keloids.  Ohio Dermatological Association’s Dermatologic News 2013;15:19.
  658. Burkhart CG.  The case of potassium iodide:  Because the newer methods of treatment are good, it does not follow that the old ones are bad.  Ohio Dermatological Association’s Dermatologic News 2013;1520.
  659. Burkhart CG.  Acne biofilm.  Journal of Clinical and Aesthetics Dermatology 2013;6:11-12.   
  660. Haydar K, Burkhart CG.  Sunscreen regulations and use of anti-inflammatory agents in sunscreens.  Dermatology Online Journal 2013;19(7):1-2.
  661. Crites MS, Burkhart CG, Burkhart CN.  The role of microbiology and biofilms in acne.  World Clinics in Dermatology 2013;1(1):1-8.
  662. Koenig KN, Burkhart CG.  Azithromycin and reported increased risk of cardiovascular death.  The Open Dermatology Journal 2012;6:55-56.
  663. Burkhart CG.  A call to remove the misnomers in dermatology.  Ohio Dermatological Association’s Dermatologic News 2014;16:16.
  664. Burkhart CG.  What serum serological studies are available if you have a possible deep fungal infection, and don’t want to do nothing while waiting the 8 to 12 weeks for culture results.  Ohio Dermatological Association’s Dermatologic News 2014;16:17.
  665. Burkhart CG.  Electronic health records: some questions about EHRs going forward.  Ohio Dermatological Association’s Dermatologic News 2014;16:18.
  666. Burkhart CG.  Kojic acid with hydroquinone improves depigmentation.  Ohio Dermatological Association’s Dermatologic News 2014;16:16.
  667. Burkhart CG.  Women itch on Venus, Men scratch on Mars.  Ohio Dermatological Association’s Dermatologic News 2014;16:18.
  668. Burkhart CG.  Carbon dioxide fumigation for controlling bed bugs.  Ohio Dermatological Association’s Dermatologic News 2014;16:19.
  669. Burkhart CG.  Wart transmission in schools.  Is this a problem?  Ohio Dermatological Association’s Dermatologic News 2014;16:20.
  670. Burkhart CG.  Why we can’t trust clinical guidelines.  Ohio Dermatological Association’s Dermatologic News 2014;16:21.
  671. Burkhart CG.  Should one review his/her revenue collection system?  Ohio Dermatological Association’s Dermatologic News 2014;16:22.
  672. Burkhart CG.  Topical glycopyrrolate for axillary hyperhidrosis?.  Ohio Dermatological Association’s Dermatologic News 2014;16:16.
  673. Burkhart CG.  The initiation of paroxysmal (intermittent) atrial fibrillation with REM sleep due to MSG and free glutamates.  International Journal of Cardiology 2013;167:2057-2058. 
  674. Burkhart CG.  OMG, contact dermatitis from mobile phone screens.  Ohio Dermatological Association’s Dermatologic News 2014;17:12.
  675. Burkhart CG.  If I had a nickel for every time I heard another source of nickel exposure.  Ohio Dermatological Association’s Dermatologic News 2014;17:13.
  676. Burkhart CG.  The #1 cause of photoallergic contact dermatitis is sunscreens.  Ohio Dermatological Association’s Dermatologic News 2014;17:14.
  677. Burkhart CG.  Fashions change, but tattoos are forever (or not).  Ohio Dermatological Association’s Dermatologic News 2014;17:15.
  678. Burkhart CG.  Internet purchase of isotretinoin.  Ohio Dermatological Association’s Dermatologic News 2014;17:16.
  679. Burkhart CG.  Isotretinoin degraded by light and oxygen.  Ohio Dermatological Association’s Dermatologic News 2014;17:17.
  680. Burkhart CG.  Sclerotherapy for digital mucous cysts.  Ohio Dermatological Association’s Dermatologic News 2014;17:18 
  681. Burkhart CG.  A farewell tribute to Mark Bechtel, dermatologist extraordinaire.  Ohio Dermatological Association’s Dermatologic News 2015;18:14
  682. Burkhart CG.  Ice anesthesia in procedural dermatology.  Ohio Dermatological Association’s Dermatologic News 2014;17:19.
  683. Burkhart CG.  Scabies treatment: oldie and cheap treatment.  Ohio Dermatological Association’s Dermatologic News 2014;17:20.
  684. Burkhart CG.  Antidotal treatment: antioxidants for skin cancer.  Ohio Dermatological Association’s Dermatologic News 2014;17:21.
  685. Burkhart CG.  Periorbital hyperpigmentation: are there treatable causes of bags under the eyes?  Ohio Dermatological Association’s Dermatologic News 2014;17:22.
  686. Burkhart CG.  A farewell tribute to Mark Bechtel, dermatologist extraordinaire.  Ohio Dermatological Association’s Dermatologic News 2015;18:14.
  687. Burkhart CG.  Drug firms redirecting pitch to hospitals and somewhat away from practicing physicians…with implications for ODA funding for annual meeting in future.  Ohio Dermatological Association’s Dermatologic News 2015;18:15.
  688. Burkhart CG.  Surgery abroad?  5% of employers are currently paying for their employees to do so, 25% say they may add this alternative in the next 3 to 5 years.  Ohio Dermatological Association’s Dermatologic News 2015;18:16.
  689. Burkhart CG.  Want excitement?  How about physician feedback/value-based payment modifier program (VBPMP to start by January 1, 2017!  Ohio Dermatological Association’s Dermatologic News 2015;18:17.
  690. Burkhart CG.  Another source of nickel dermatitis…razors and laptops.  Ohio Dermatological Association’s Dermatologic News 2015;18:18.
  691. Burkhart CG.  With perianal dermatitis, think methylisothiazolinone.  Ohio Dermatological Association’s Dermatologic News 2015;18:19.
  692. Burkhart CG.  A new antibiotic on the block for gram-positive pathogens.  Ohio Dermatological Association’s Dermatologic News 2015;18:20.
  693. Burkhart CG.  Differentiation of psoriasis and dermatitis by gene testing.  Ohio Dermatological Association’s Dermatologic News 2015;18:21.
  694. Burkhart CG.  Sunbathing still has its proponents.  Ohio Dermatological Association’s Dermatologic News 2015;18:22.
  695. Burkhart CG.  Another article from England stating high incidence of photoallergic reactions to sunscreen ingredients.  Ohio Dermatological Association’s Dermatologic News 2015;18:23.
  696. Burkhart CG.  Women who have many moles on their skin are slightly more prone to breast cancer.  Ohio Dermatological Association’s Dermatologic News 2015;18:25.
  697. Burkhart CG.  The human skin microbiome:  analysis of all microbes found in the on the human being.  Ohio Dermatological Association’s Dermatologic News 2015;18:26.
  698. Burkhart CG.  The introduction of a National Quadrivalent Human Papillomavirus Vaccination Program for young women in Denmark in 2009 has proved successful.  Ohio Dermatological Association’s Dermatologic News 2015;18:27.
  699. Burkhart CG.  Women who have many moles on their skin are slightly more prone to breast cancer.  Ohio Dermatological Association’s Dermatologic News 2015;18:25.
  700. Burkhart CG.  The ugly civil war in American medicine exposed.  Ohio Dermatological Association’s Dermatologic News 2015;19:15
  701. Burkhart CG.  Patient fees soar when hospitals buy doctor’s offices.  Ohio Dermatological Association’s Dermatologic News 2015;19:16.
  702. Burkhart CG. Dangerous pathogens, once partially tweaked for task, will become part of the medical weaponry.  Ohio Dermatological Association’s Dermatologic News 2015;19:17.
  703. Burkhart CG.  Confucius usage in clinical practice: wisdom and proper names. Ohio Dermatological Association’s Dermatologic News 2015;19:20.
  704. Burkhart CG.  Self-injection of dermal fillers is on the rise.  Ohio Dermatological Association’s Dermatologic News 2015;19:21.
  705. Burkhart CG. Microsporum canis is transmittable person-to-person. Ohio Dermatological Association’s Dermatologic News 2015;19:22.
  706. Burkhart CG.  We’ve got a friend in the press, namely Charles Krauthammer.  Ohio Dermatological Association’s Dermatologic News 2015;19:23.
  707. Mohammad T, Burkhart CG.  Acne therapeutics:  A closer look at benzoyl peroxide.  SkinMed 2015;13;94-96. 
  708. Burkhart CG.  Identity thieves in medicine. Ohio Dermatological Association’s Dermatologic News 2016;20:8.
  709. Burkhart CG.  Cancer-driving mutations in normal cells all the time. Ohio Dermatological Association’s Dermatologic News 2016;20:9.
  710. Burkhart CG.  Can private dermatologists as self-employed medical providers survive?  Ohio Dermatological Association’s Dermatologic News 2016;20:10.
  711. Burkhart CG.  Corporate titans versus organized medicine, one twist to Scheinfeld’s doomsday.  Ohio Dermatological Association’s Dermatologic News 2016;20:11.
  712. Burkhart CG.  Forensic medicine and dermatology. Ohio Dermatological Association’s Dermatologic News 2016;20:12.
  713. Burkhart CG.  Skin cells transformed into nerve cells.  Ohio Dermatological Association’s Dermatologic News 2016;20:13.
  714. Burkhart CG.  Kybella by Kythera, an injectable agent for the improvement of submental fat in adults and me.  Ohio Dermatological Association’s Dermatologic News 2016;20:14.
  715. Burkhart CG.  Acne plugging continues to be assessed.  Ohio Dermatological Association’s Dermatologic News 2016;20:15.
  716. Burkhart CG.  Is there a problem wearing occlusive gloves for a prolonged time in the work environment?  Ohio Dermatological Association’s Dermatologic News 2016;20:16.
  717. Burkhart CG.  Alteration of epidermal proteins in chronic hand dermatitis.  What does it all mean?  Ohio Dermatological Association’s Dermatologic News 2016;20:17.
  718. Burkhart CG.  Hidradenitis suppurtiva treated with spironolactone. Ohio Dermatological Association’s Dermatologic News 2016;20:18.
  719. Schloemer JA, Zirwas M, Burkhart CG.  Differentiation of latex allergy from irritant contact dermatitis.  Cutis 2015;96:369-371. 
  720. Schloemer JA, Zirwas M, Burkhart CG.  Airborne contact dermatitis.  International Journal of Dermatology 2015;54:271-75.
  721. Metiko B, Brooks K, Burkhart CG, Burkhart CN.  Is the current model for acne pathogenesis backwards?  Journal of the American Academy of Dermatology 2015;72:e167. 
  722. Burkhart CG, Schloemer J, Zirwas M.  Differentiation of latex allergy from irritant contact dermatitis.  Cutis 2015;96:369-401.
  723. Burkhart CG.  Book review on Hair: A Human History by Kurt Stein. Ohio Dermatological Association’s Dermatologic News 2016;21:10.
  724. Burkhart CG.  New diagnosis of topical steroid damaged/dependent skin (TSDF) which is defined as an addiction to topical steroids.  Ohio Dermatological Association’s Dermatologic News 2016;21:11.
  725. Burkhart CG.  New study reveals chocolate exacerbates acne.  Ohio Dermatological Association’s Dermatologic News 2016;21:12.
  726. Burkhart CG.  ‘Washout’ period of oral tetracycline antibiotics prior to systemic isotretinoin?  Ohio Dermatological Association’s Dermatologic News 2016;21:13.
  727. Burkhart CG.  Another study for low dosing with isotretinoin.  Ohio Dermatological Association’s Dermatologic News 2016;21:14.
  728. Burkhart CG.  Atopics and methicillin-resistant Staphylococcus aureus (MRSA):  a growing problem?  Ohio Dermatological Association’s Dermatologic News 2016;21:15.
  729. Burkhart CG.  Hard water definitely affects hair microscopically.  Ohio Dermatological Association’s Dermatologic News 2016;21:16.
  730. Burkhart CG.  Skin soaks up toxic air pollutants.  Ohio Dermatological Association’s Dermatologic News 2016;21:17.
  731. Burkhart CG.  Now we have artificial skin that can feel heat and hear sound.  Ohio Dermatological Association’s Dermatologic News 2016;21:18.
  732. Burkhart CG.  Give oral zinc a try in alopecia areata patients.  Ohio Dermatological Association’s Dermatologic News 2016;21:19.
  733. Burkhart CG.  Consider parasites including protozoa for chronic urticaria.  Ohio Dermatological Association’s Dermatologic News 2016;21:20.
  734. Shah G, Gottwald L, Shesky A, Burkhart CG.  Pyogenic granuloma: a rare presentation and a rapid resolution.  The Open Dermatology Journal 2018;12:65-69.
  735. Burkhart CG.  Residential and occupational exposure to pesticides may increase risk for cutaneous melanoma. Ohio Dermatological Association’s Dermatologic News 2016;21:21.
  736. Burkhart CG.  Laser treatment alters melanocytic nevi.  Ohio Dermatological Association’s Dermatologic News 2016;21:22. 
  737. Burkhart CG.  New antibiotics against MRSA.  Ohio Dermatological Association’s Dermatologic News 2017;22:9.
  738. Burkhart CG.  Prolonged use of antibiotics might fight off Alzheimer’s.  Ohio Dermatological Association’s Dermatologic News 2017;22:10.
  739. Burkhart CG.  Information not to share with patients who have delusions of parasitosis.  Ohio Dermatological Association’s Dermatologic News 2017;22:11.
  740. Burkhart CG.  Ultraviolet light from nearby stars and other galaxies.  Ohio Dermatological Association’s Dermatologic News 2017;22:12.
  741. Burkhart CG.  New clothing fad could be plastic ling wrap with nano-sized pores.  Ohio Dermatological Association’s Dermatologic News 2017;22:13.
  742. Burkhart CG.  Roller coaster rides knock out kidney stones.  Ohio Dermatological Association’s Dermatologic News 2017;22:14.
  743. Burkhart CG.  Squirrels in Great Britain and Ireland harbor leprosy.  Ohio Dermatological Association’s Dermatologic News 2017;22:15.
  744. Burkhart CG.  A rise in sexually transmitted disease in America.  Ohio Dermatological Association’s Dermatologic News 2017;22:16.
  745. Burkhart CG.  Many patients with latex allergy, actually have glove related hand urticaria.  Ohio Dermatological Association’s Dermatologic News 2017;22:17.
  746. Burkhart CG.  Television alopecia – a new entity uncovered.  Ohio Dermatological Association’s Dermatologic News 2017;22:18.
  747. Peyton GE, Burkhart, CG.  Temporary henna tattooing: a case of contact dermatitis.  The Open Dermatology Journal 2016;10:82-84.
  748. Burkhart CG.  Gene editing helps cows fight tuberculosis. Ohio Dermatological Association’s Dermatologic News 2017:23:11.
  749. Burkhart CG.  New methods of producing better antibiotics.  Ohio Dermatological Association’s Dermatologic News 2017:23:12.
  750. Burkhart CG.  A review of moisturizers.  Ohio Dermatological Association’s Dermatologic News 2017:23:13.
  751. Burkhart CG.  Data breaches a near certainty.  Ohio Dermatological Association’s Dermatologic News 2017:23:14.
  752. Burkhart CG.  Simple treatment for IgA dermatosis. Ohio Dermatological Association’s Dermatologic News 2017:23:15.
  753. Sefcik R, Burkhart CG.  Wart immunotherapies:  A short review.  The Open Dermatology Journal 2017;11:30-34.
  754. Sefcik R, Burkhart CG.  Infection with Human Papillomavirus:  Are Intralesional therapies a promising approach?  Journal of Dermatology and Plastic Surgery (accepted 2017).
  755. Burkhart CG.  Quantum dots making bacteria more vulnerable.  Ohio Dermatological Association’s Dermatologic News 2018:24:6,
  756. Burkhart CG.  Sunless tanner that protects skin by upping melanin production without ultraviolet radiation.  Ohio Dermatological Association’s Dermatologic News 2018:24:7.
  757. Burkhart CG.  HIV has found broad defense against AIDS virus in cow.  Ohio Dermatological Association’s Dermatologic News 2018:24:8.
  758. Burkhart CG.  Flu shots to be dermal….in the future.  Ohio Dermatological Association’s Dermatologic News 2018:24:9.
  759. Burkhart CG.  Do males taking antimetabolites and biologics have a risk of adverse fetal outcomes?  Ohio Dermatological Association’s Dermatologic News 2018:24:10.
  760. Burkhart CG.  Staphylococcus and atopy.  Ohio Dermatological Association’s Dermatologic News 2018:24:11.
  761. Burkhart CG.  A recent use of psoralens and light reported.  Ohio Dermatological Association’s Dermatologic News 2018:24:12.
  762. Burkhart CG.  Wet wrap treatments for atopy gets negative review.  Ohio Dermatological Association’s Dermatologic News 2018:24:13.
  763. Burkhart CG.  Alopecia areata treatment options discussed.  Ohio Dermatological Association’s Dermatologic News 2018:24:14.
  764. Burkhart CG.  Halo nevus…is it a good or bad thing?  Ohio Dermatological Association’s Dermatologic News 2018:24:15.
  765. Burkhart CG.  The bone has endocrine-like functions…it isn’t a dead organ.  Ohio Dermatological Association’s Dermatologic News 2018;24:16. 
  766. Sefcik RS, Burkhart CG.  Infections with human papillomavirus:  Are intralesional therapies a promising approach?  Journal of Dermatology and Plastic Surgery.  2018:3:1-2. 
  767. Burkhart, CG.  Patient informational sheet on why some physicians are hesitant to prescribe biologics.  The Open Dermatology Journal 2018;12:3-4.
  768. Shah J, Gottwald L, Sheskey A, Burkhart CG.  Pyoderma gangrenosum of the face:  a rare presentation and a rapid resolution.  The Open Dermatology Journal 2018;12:59-62. 
  769. Burkhart CG.  Patient informational sheet on why some physicians are hesitant to prescribe biologics.  The Open Dermatology Journal 2018:12:12-13.
  770. Gaishauser K, Burkhart CG.  Reexamination of treatment of seborrheic keratoses given availability of new prescription therapy with hydrogen peroxide.  The Open Dermatology 2018:12:86-89.
  771. Gowda A, Burkhart CG.  Virulent acne biofilms offer insight into novel therapeutic options.  The Open Dermatology Journal 2018;12:80-85. 
  772. Grishauser K, Burkhart CG, Bimodal temporal distribution of herpes explains resistant cases to oral antiviral agents.  The Open Dermatology Journal 2019;13:1-2. 
  773. Gowda A, Burkhart CG.  Topical retinoids prevent P. acne biofilm.  Dermatology Times 2019;40(3): 24-25.
  774. Anzelc MJ, Burkhart CG.  Crisaborole: Application pain and prevention.  The Open Dermatology Journal 2019;13:55-57.
  775. Anzelc MJ, Burkhart CG.  Pain and pruritus:  A study of their similarities and differences.  International Journal of Dermatology 2020;59:159-164. 
  776. Balasubramaniam D, Burkhart CG.  Hydrogen peroxide use for chemical destruction on seborrheic keratoses:  a review.  The Open Dermatology Journal 2020:14:1-5. 
  777. Burkhart, CG.  Infection Control in a dermatology office during a coronavirus epidemic:  Let’s get down to specifics which includes the auto visitation.  The Open Dermatology Journal, 2020: 15:6-8
  778. Burkhart, CG.  Ozone disinfectants like SoClean CPAP Sanitizer can be used to sterilize cloth and n95 masks in the protection against COVID-10, The Open Dermatology Journal 2020; 14:14-15. 
  779. Burkhart CG.  My journey of formulating a patent for topical/spray ivermectin against COVID.  The Open Dermatology Journal 2021:15;1-2. 
  780. Stetkevich S, Burkhart CG.  Light’s progression as an immunomodulation therapy.  International Journal of Dermatology 2022;61:203-204.
  781. Anzelc MJ, Burkhart CG.  Can artificial intelligence technology replace human scribes?  Cutis 2021:108:310-311. 
  782. Anzelc MJ, Burkhart, CG.  Dimethyl sulphoxide: A practical adjunct to combat pain and pruritus.  The Dermatology Online Journal 2021;27(11):2-7. 
  783. Shetkevich S, Burkhart CG.  The dangers of HPV laser plume and best safety practices.  International Journal of Dermatology 2023;62:32-34.
  784. Anzelc MJ, Burkhart CG.  Preliminary observations regarding soaps and slipperiness in bathroom injuries.  The Open Dermatology Journal 2022:16;3187437222201040
  785. Marellapudi A, Burkhart CG.  Implications of the gut-brain-skin axis affecting the skin and specifically C. acnes.  International Journal of Dermatology 2023;62:295-6. 
  786. Gupta M, Shetkevich S, Anzelc MJ, Burkhart, CG.  Bacteriophages:  An alternative to combat bacterial resistance.  Journal of Drugs in Dermatology 2022;21:1311-5. 
  787. Caudill J, Thomas J, Burkhart, CG.  The risk of metastases from squamous cell carcinoma of the skin.  International Journal of Dermatology (accepted 2022).
  788.  Sketkevich S, Anzelc MJ, Burkhart CG.  Intranasal ivermectin spray, the sunscreen to COVID-19.  The Open Dermatology Journal 2022:16:e187437222015190. 
  789. Burkhart CG. Safer and more broad-spread UV protection available in other countries:  Need for FDA approval for public health of Americans STAT.  The Open Dermatology Journal 2022;16:1-5  e187437222208110 
  790. Koka S, Burkhart CG.  Artificial intelligence in dermatology:  current use, shortfalls, and potential opportunities of further implementation in diagnosis and care.  The Open Dermatology Journal 2023;17:e1874372222304140.
  791. Burkhart CG.  Sequelae of financial toxicity of biologics and JAK inhibitors in the United States: Health insurance companies may eliminate dermatology form list of specialists in their physician panel.  The Open Dermatology 2023;17:e1874372222304180.
  792. Bush M, Burkhart CG.  Pesticides and pollutants associated with rising cases of melanoma.  The Open Dermatology Journal 2023;17:e187437222306190. 
  793.  Scott E, Burkhart CG.  Cutibacterium acnes as a cause of post-surgical prosthesis infection.  The Open Dermatology Journal 2023:17:e187437222309130. 
  794. Scott E, Burkhart, Elston D.  S. scabiei and the immune system, Part 1.  Cutis (accepted 2023)
  795. Scott E. Burkhart CG, Elston D.  S. scabiei and the immune system, Part 2.  Cutis (accepted 2023) 
  796. Kuka S, Burkhart, CG.  Baricitinib: Exploring the safety profile for the treatment of alopecia areata.  The Open Dermatology Journal 2023;17:e187437222260273. 
  797. Burkhart CG.  Transference in contact dermatitis:  new name for underappreciated cause of eczema.  The Open Dermatology Journal. 2023; 17: e18743722272472. 
  798. Burkhart CG.  MRSA from wrestlers at high school in Toledo area with bacterial sensitivities making it easy to treat.  Ohio Dermatology Association Newsletter 2024;25:3-5. 
  799. Burkhart CG.  Assessment of Cutibacterium acnes, acne biofilm, comedones, ant future treatments for acne.  The Open Dermatology Journal 2024;18:e18743722279314.
  800. Scott E, Burkhart CG.  A review of the relationship between Cutibacterium acnes biofilm and keratosis pilaris.  Journal of the American Academy of Dermatology Review (under review 2024).
  801. Ambardekas, S, Burkhart CG.  Evaluating the role of topical immunostimulants for molluscum contagiosum:  A review.  The Open Dermatology Journal (under review 2024).
  802. Burkhart CG.  Scabies epidemiologic assessment: Actuality of airborne transmission and additional standards to reduce spread of contagion and reinfestation.  The Open Dermatology Journal (accepted but not in print yet, 2024). 
  803. Quillan K, Buck B, Burkhart CG.  The management of wrestlers with cutaneous infections.  International Journal of Dermatology (under review). 
  804. Scott E, Burkhart CG.  The role of Cutibacterium acnes and its biofilm in dandruff pathogenesis.  Journal of the American Academy of Dermatology Reviews (under review).    
As in all medical fields, the specialty of dermatology requires mutual understanding, respect, and confidence.  We try to offer patients high standards of dermatologic medical care.  If you have questions, or concerns about any part of your care, treatment, or medication, please bring them to our attention.  Should you encounter any difficulties with medications or treatment, contact our office immediately.  Thank you for coming to us for your dermatological care.  We appreciate your confidence.

Testimonials:

"He is my kind of doctor. No nonsense, to the point and does not have you keep coming back for rechecks. Very kind, knowledgeable. A scholar in his field!"

"If you are looking for a doctor with care and compassion then Dr. Burkhart would be a great choice."

"Just a great experience. I have been to see Dr. Burkhart several times. Always sees me promptly, treats me first visit in the most effecient manner. This is the way all medical offices should be run. Thanks to you and your staff!"

"The appointment time was right on schedule, the doc was friendly and helpful. But what impressed me the most was that he took care of my problem right away. No follow ups, no rescheduled appointments. Just fixed my problem right away. Great job. If you need something removed give him a call."

"Easy to arrange an appt upon arrival was on time to see me. Checked me over thoroughly and explained all he saw."

"Excellent physician. Best dermatologist in Toledo!"

"My experience at Dr. Burhart office was amazing he was very understanding. His staffs were very helpful, they were able to answered all my questions, and extremely patient with me. Thank you so much for making me feel comfortable and keeping my records up-to-date immediately."


Office Hours:

Monday      9:00 - 4:30
Tuesday      9:00 - 4:00
Wedneday  8:30 - 12:00
Thursday    9:00 - 5:00
Friday         8:30 -12:00
 
 Call 419-885-3403 for an appointment!

Fax ~ 419-885-3401
Our office is at:
5600 Monroe Street
Building B ~ Suite 106B
Sylvania, Ohio
43560
Near the Monroe exit of Interstate 23
 
 
 
 

 

 
 

© Craig Burkhart MD, Inc


5600 Monroe Street
Building B ~ Suite 106B
Sylvania, Ohio
43560

Phone: 419-885-3403
 
 
Click to visit Pappy Productions, Inc.